Contaminated. Shown to be a Reh derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a Reh derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a Reh derivative (PubMed=12592342; PubMed=20143388).
Partially contaminated. Some laboratories that are redistributing this cell line are in fact redistributing a contaminated cell line of mouse origin (PubMed=25182563).
Partially contaminated. Some laboratories that are redistributing this cell line are in fact redistributing a contaminated cell line of mouse origin (PubMed=25182563).
Partially contaminated. Some laboratories that are redistributing this cell line are in fact redistributing a contaminated cell line of mouse origin (PubMed=25182563).
Partially contaminated. Some laboratories that are redistributing this cell line are in fact redistributing a contaminated cell line of mouse origin (PubMed=25182563).
Partially contaminated. Some laboratories that are redistributing this cell line are in fact redistributing a contaminated cell line of mouse origin (PubMed=25182563).
Partially contaminated. Some laboratories that are redistributing this cell line are in fact redistributing a contaminated cell line of mouse origin (PubMed=25182563).
Partially contaminated. Some laboratories that are redistributing this cell line are in fact redistributing a contaminated cell line of mouse origin (PubMed=25182563).
Misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line.
Misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line.
Misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line.
Misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line.
Misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line.
Misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line.
Misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line.
Misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line.
Misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line.
Misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line.
Misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line.
Misidentified. Originally thought to be a hepatocellular carcinoma cell line but shown to be from an hepatoblastoma (PubMed=19751877).
Misidentified. Originally thought to be a hepatocellular carcinoma cell line but shown to be from an hepatoblastoma (PubMed=19751877).
Misidentified. Originally thought to be a hepatocellular carcinoma cell line but shown to be from an hepatoblastoma (PubMed=19751877).
Misidentified. Originally thought to be a hepatocellular carcinoma cell line but shown to be from an hepatoblastoma (PubMed=19751877).
Misidentified. Originally thought to be a hepatocellular carcinoma cell line but shown to be from an hepatoblastoma (PubMed=19751877).
Misidentified. Originally thought to be a hepatocellular carcinoma cell line but shown to be from an hepatoblastoma (PubMed=19751877).
Misidentified. Originally thought to be a rhabdomyosarcoma cell line but shown to be from an Ewing sarcoma (PubMed=10379870; PubMed=12606131; PubMed=14697648).
Misidentified. Originally thought to be a rhabdomyosarcoma cell line but shown to be from an Ewing sarcoma (PubMed=10379870; PubMed=12606131; PubMed=14697648).
Misidentified. Originally thought to be a rhabdomyosarcoma cell line but shown to be from an Ewing sarcoma (PubMed=10379870; PubMed=12606131; PubMed=14697648).
Misidentified. Originally thought to be a rhabdomyosarcoma cell line but shown to be from an Ewing sarcoma (PubMed=10379870; PubMed=12606131; PubMed=14697648).
Contaminated. Grand-parent cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Grand-parent cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Grand-parent cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Parent cell line (OV-2008) has been shown to be a ME-180 derivative (PubMed=22710073).
Contaminated. Parent cell line (OV-2008) has been shown to be a ME-180 derivative (PubMed=22710073).
Contaminated. Parent cell line (OV-2008) has been shown to be a ME-180 derivative (PubMed=22710073).
Contaminated. Parent cell line (OV-2008) has been shown to be a ME-180 derivative (PubMed=22710073).
Contaminated. Parent cell line (OV-2008) has been shown to be a ME-180 derivative (PubMed=22710073).
Contaminated. Parent cell line (OV-2008) has been shown to be a ME-180 derivative (PubMed=22710073).
Contaminated. Parent cell line (OV-2008) has been shown to be a ME-180 derivative (PubMed=22710073).
Contaminated. Parent cell line (OV-2008) has been shown to be a ME-180 derivative (PubMed=22710073).
Contaminated. Parent cell line (OV-2008) has been shown to be a ME-180 derivative (PubMed=22710073).
Contaminated. Parent cell line (OV-2008) has been shown to be a ME-180 derivative (PubMed=22710073).
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a breast squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a breast squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a breast squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a breast squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a breast squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a breast squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a breast squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a breast squamous cell carcinoma.
Misidentified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170).
Misidentified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170).
Misidentified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170).
Misidentified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170).
Misidentified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170).
Misidentified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170).
Misidentified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170).
Misidentified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=1246601; PubMed=20143388). Originally thought to originate from normal liver hepatic cells.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=1246601; PubMed=20143388). Originally thought to originate from normal liver hepatic cells.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=1246601; PubMed=20143388). Originally thought to originate from normal liver hepatic cells.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=1246601; PubMed=20143388). Originally thought to originate from normal liver hepatic cells.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=1246601; PubMed=20143388). Originally thought to originate from normal liver hepatic cells.
Misidentified. Originally thought to be a Wilms tumor cell line but is a kidney rhabdoid tumor cell line (PubMed=8382007).
Misidentified. Originally thought to be a Wilms tumor cell line but is a kidney rhabdoid tumor cell line (PubMed=8382007).
Misidentified. Originally thought to be a Wilms tumor cell line but is a kidney rhabdoid tumor cell line (PubMed=8382007).
Possibly contaminated. The STR profile is very similar to that of the HelA cell line and almost identical to that of HNE-2 (CVCL_FA07).
Possibly contaminated. The STR profile is very similar to that of the HelA cell line and almost identical to that of HNE-2 (CVCL_FA07).
Contaminated. Parent cell line (HO-8910) has been shown to be a HeLa derivative (CCRID).
Contaminated. Parent cell line (HO-8910) has been shown to be a HeLa derivative (CCRID).
Contaminated. Parent cell line (HO-8910) has been shown to be a HeLa derivative (CCRID).
Contaminated. Parent cell line (HO-8910) has been shown to be a HeLa derivative (CCRID).
Contaminated. Parent cell line (HO-8910) has been shown to be a HeLa derivative (CCRID).
Contaminated. Shown to be a RD derivative (PubMed=1620276).
Contaminated. Shown to be a RD derivative (PubMed=1620276).
Contaminated. Shown to be a RD derivative (PubMed=1620276).
Contaminated. Shown to be a RD derivative (PubMed=1620276).
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=1246601; PubMed=20143388). Originally thought to originate from an epidermal carcinoma of the mouth.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=1246601; PubMed=20143388). Originally thought to originate from an epidermal carcinoma of the mouth.
Contaminated. Shown to be a M14 derivative (PubMed=17004106; PubMed=20143388; PubMed=28940260). Originally thought to originate from a breast carcinoma. See also PubMed=19549886 for a dissenting but incorrect view that states that M14 is a breast cancer cell line.
Contaminated. Shown to be a M14 derivative (PubMed=17004106; PubMed=20143388; PubMed=28940260). Originally thought to originate from a breast carcinoma. See also PubMed=19549886 for a dissenting but incorrect view that states that M14 is a breast cancer cell line.
Contaminated. Shown to be a M14 derivative (PubMed=17004106; PubMed=20143388; PubMed=28940260). Originally thought to originate from a breast carcinoma. See also PubMed=19549886 for a dissenting but incorrect view that states that M14 is a breast cancer cell line.
Contaminated. Shown to be a M14 derivative (PubMed=17004106; PubMed=20143388; PubMed=28940260). Originally thought to originate from a breast carcinoma. See also PubMed=19549886 for a dissenting but incorrect view that states that M14 is a breast cancer cell line.
Contaminated. Shown to be a M14 derivative (PubMed=17004106; PubMed=20143388; PubMed=28940260). Originally thought to originate from a breast carcinoma. See also PubMed=19549886 for a dissenting but incorrect view that states that M14 is a breast cancer cell line.
Contaminated. Shown to be a M14 derivative (PubMed=17004106; PubMed=20143388; PubMed=28940260). Originally thought to originate from a breast carcinoma. See also PubMed=19549886 for a dissenting but incorrect view that states that M14 is a breast cancer cell line.
Contaminated. Shown to be a M14 derivative (PubMed=17004106; PubMed=20143388; PubMed=28940260). Originally thought to originate from a breast carcinoma. See also PubMed=19549886 for a dissenting but incorrect view that states that M14 is a breast cancer cell line.
Contaminated. Shown to be a M14 derivative (PubMed=17004106; PubMed=20143388; PubMed=28940260). Originally thought to originate from a breast carcinoma. See also PubMed=19549886 for a dissenting but incorrect view that states that M14 is a breast cancer cell line.
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. NCI-H157 and NCI-H1264 have been shown to be identical.
Contaminated. NCI-H157 and NCI-H1264 have been shown to be identical.
Contaminated. NCI-H157 and NCI-H1264 have been shown to be identical.
Contaminated. NCI-H157 and NCI-H1264 have been shown to be identical.
Contaminated. NCI-H157 and NCI-H1264 have been shown to be identical.
Contaminated. NCI-H157 and NCI-H1264 have been shown to be identical.
Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a ME-180 derivative (PubMed=22570425).
Contaminated. Shown to be a ME-180 derivative (PubMed=22570425).
Contaminated. Shown to be a ME-180 derivative (PubMed=22570425).
Contaminated. Shown to be a ME-180 derivative (PubMed=22570425).
Contaminated. Shown to be a ME-180 derivative (PubMed=22570425).
Contaminated. Shown to be a ME-180 derivative (PubMed=22570425).
Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=20143388; PubMed=20421273). Originally thought to originate from the peripheral blood of a 69 year old male with acute myeloid leukemia.
Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=20143388; PubMed=20421273). Originally thought to originate from the peripheral blood of a 69 year old male with acute myeloid leukemia.
Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=20143388; PubMed=20421273). Originally thought to originate from the peripheral blood of a 69 year old male with acute myeloid leukemia.
Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=20143388; PubMed=20421273). Originally thought to originate from the peripheral blood of a 69 year old male with acute myeloid leukemia.
Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=20143388; PubMed=20421273). Originally thought to originate from the peripheral blood of a 69 year old male with acute myeloid leukemia.
Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=20143388; PubMed=20421273). Originally thought to originate from the peripheral blood of a 69 year old male with acute myeloid leukemia.
Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=20143388; PubMed=20421273). Originally thought to originate from the peripheral blood of a 69 year old male with acute myeloid leukemia.
Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=20143388; PubMed=20421273). Originally thought to originate from the peripheral blood of a 69 year old male with acute myeloid leukemia.
Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=20143388; PubMed=20421273). Originally thought to originate from the peripheral blood of a 69 year old male with acute myeloid leukemia.
Contaminated. Shown to be a SCCKN derivative (PubMed=16643607; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=26116706; PubMed=28851942). Originally thought to originate from the lymph node of a 56 year old female patient with a gastric carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706; PubMed=28851942). Originally thought to originate from the lymph node of a 56 year old female patient with a gastric carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706; PubMed=28851942). Originally thought to originate from the lymph node of a 56 year old female patient with a gastric carcinoma.
Misidentified. Originally thought to be a neuroblastoma cell line but shown to be from an Askin tumor (PubMed=20143388).
Misidentified. Originally thought to be a neuroblastoma cell line but shown to be from an Askin tumor (PubMed=20143388).
Misidentified. Originally thought to be a neuroblastoma cell line but shown to be from an Askin tumor (PubMed=20143388).
Misidentified. Originally thought to be a neuroblastoma cell line but shown to be from an Askin tumor (PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=26116706; PubMed=28807831). Originally thought to originate from a hepatocellular carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706; PubMed=28807831). Originally thought to originate from a hepatocellular carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706; PubMed=28807831). Originally thought to originate from a hepatocellular carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706; PubMed=28807831). Originally thought to originate from a hepatocellular carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706; PubMed=28807831). Originally thought to originate from a hepatocellular carcinoma.
Contaminated. Shown to be a U-251MG derivative (PubMed=20143388; PubMed=22570425). Originally thought to originate from a 47 year old patient with a left parieto-occipital glioblastoma.
Contaminated. Shown to be a U-251MG derivative (PubMed=20143388; PubMed=22570425). Originally thought to originate from a 47 year old patient with a left parieto-occipital glioblastoma.
Contaminated. Shown to be a U-251MG derivative (PubMed=20143388; PubMed=22570425). Originally thought to originate from a 47 year old patient with a left parieto-occipital glioblastoma.
Probably misidentified. Said to originate from fibroblasts of the lung of a male black individual (CLS), but in reality seems to be established from skin fibroblast of an adult female (strain A). Note that some papers have probably missasigned it to be from a Fanconi anemia patient.
Probably misidentified. Said to originate from fibroblasts of the lung of a male black individual (CLS), but in reality seems to be established from skin fibroblast of an adult female (strain A). Note that some papers have probably missasigned it to be from a Fanconi anemia patient.
Probably misidentified. Said to originate from fibroblasts of the lung of a male black individual (CLS), but in reality seems to be established from skin fibroblast of an adult female (strain A). Note that some papers have probably missasigned it to be from a Fanconi anemia patient.
Probably misidentified. Said to originate from fibroblasts of the lung of a male black individual (CLS), but in reality seems to be established from skin fibroblast of an adult female (strain A). Note that some papers have probably missasigned it to be from a Fanconi anemia patient.
Probably misidentified. Said to originate from fibroblasts of the lung of a male black individual (CLS), but in reality seems to be established from skin fibroblast of an adult female (strain A). Note that some papers have probably missasigned it to be from a Fanconi anemia patient.
Probably misidentified. Said to originate from fibroblasts of the lung of a male black individual (CLS), but in reality seems to be established from skin fibroblast of an adult female (strain A). Note that some papers have probably missasigned it to be from a Fanconi anemia patient.
Partially contaminated. Some stocks of UROTsa are contaminated with T24 (PubMed=23691160). However it must be noted that the stocks from the laboratory distributing/curating this cell line are not contaminated; therefore the contamination event has probably occurred through secondary sources after UROtsa was given to other investigators (PubMed=26783756).
Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to be a hepatic fetal epithelial cell line.
Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to be a hepatic fetal epithelial cell line.
Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to be a hepatic fetal epithelial cell line.
Contaminated. Parent cell line (YMB-1) has been shown to be a ZR-75-1 derivative.
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Misidentified. Originally thought to be a Wilm's tumor cell line but shown to be from an Ewing sarcoma (PubMed=17154184).
Misidentified. Originally thought to be a Wilm's tumor cell line but shown to be from an Ewing sarcoma (PubMed=17154184).
Misidentified. Originally thought to be a Wilm's tumor cell line but shown to be from an Ewing sarcoma (PubMed=17154184).
Misidentified. Originally thought to be a Wilm's tumor cell line but shown to be from an Ewing sarcoma (PubMed=17154184).
Contaminated. Shown to be a U-138MG derivative (PubMed=20143388).
Contaminated. Shown to be a U-138MG derivative (PubMed=20143388).
Contaminated. Shown to be a U-138MG derivative (PubMed=20143388).
Contaminated. Shown to be a U-138MG derivative (PubMed=20143388).
Contaminated. Shown to be a U-138MG derivative (PubMed=20143388).
Contaminated. Shown to be a U-138MG derivative (PubMed=20143388).
Contaminated. Shown to be a U-138MG derivative (PubMed=20143388).
Contaminated. Shown to be a U-138MG derivative (PubMed=20143388).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line but is a B-lymphoblastoid cell line (PubMed=12592342; PubMed=29533902).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line but is a B-lymphoblastoid cell line (PubMed=12592342; PubMed=29533902).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line but is a B-lymphoblastoid cell line (PubMed=12592342; PubMed=29533902).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line but is a B-lymphoblastoid cell line (PubMed=12592342; PubMed=29533902).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line but is a B-lymphoblastoid cell line (PubMed=12592342; PubMed=29533902).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line but is a B-lymphoblastoid cell line (PubMed=12592342; PubMed=29533902).
Contaminated. Parent cell line (KM20) has been shown to be a HT-29 derivative.
Contaminated. Parent cell line (KM20) has been shown to be a HT-29 derivative.
Contaminated. Parent cell line (KM20) has been shown to be a HT-29 derivative.
Contaminated. Parent cell line (KM20) has been shown to be a HT-29 derivative.
Contaminated. Parent cell line (MV-522) has been shown to be a HT-29 derivative.
Contaminated. Parent cell line (MV-522) has been shown to be a HT-29 derivative.
Misidentified. Originally thought to be THP-1 (PubMed=10721995) but later shown to be a derivative of Raji (PubMed=14972530).
Contaminated. Shown to be a HeLa derivative (PubMed=23136038).
Contaminated. Shown to be a HeLa derivative (PubMed=23136038).
Contaminated. Shown to be a HeLa derivative (PubMed=23136038).
Contaminated. Shown to be a HeLa derivative (PubMed=23136038).
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=7579375; PubMed=10516762).
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=7579375; PubMed=10516762).
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=7579375; PubMed=10516762).
Contaminated. Shown to be a Peer derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a 11 year old patient with T-ALL.
Contaminated. Shown to be a Peer derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a 11 year old patient with T-ALL.
Contaminated. Shown to be a Peer derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a 11 year old patient with T-ALL.
Contaminated. Shown to be a Peer derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a 11 year old patient with T-ALL.
Possibly misidentified. It is not certain that this cell line originate from a hairy cell leukemia (PubMed=22653958).
Possibly misidentified. It is not certain that this cell line originate from a hairy cell leukemia (PubMed=22653958).
Possibly misidentified. It is not certain that this cell line originate from a hairy cell leukemia (PubMed=22653958).
Possibly misidentified. It is not certain that this cell line originate from a hairy cell leukemia (PubMed=22653958).
Partially contaminated. Some stocks of Ca9-22 are contaminated with MSK-922 (PubMed=21868764).
Partially contaminated. Some stocks of Ca9-22 are contaminated with MSK-922 (PubMed=21868764).
Partially contaminated. Some stocks of Ca9-22 are contaminated with MSK-922 (PubMed=21868764).
Partially contaminated. Some stocks of Ca9-22 are contaminated with MSK-922 (PubMed=21868764).
Partially contaminated. Some stocks of Ca9-22 are contaminated with MSK-922 (PubMed=21868764).
Contaminated. Shown to be a SW579 derivative (PubMed=25877200, DSMZ). Originally thought to originate from a thyroid gland follicular carcinoma metastasizing to the sternum of a 70 year old Chinese female patient.
Contaminated. Shown to be a SW579 derivative (PubMed=25877200, DSMZ). Originally thought to originate from a thyroid gland follicular carcinoma metastasizing to the sternum of a 70 year old Chinese female patient.
Contaminated. Shown to be a SW579 derivative (PubMed=25877200, DSMZ). Originally thought to originate from a thyroid gland follicular carcinoma metastasizing to the sternum of a 70 year old Chinese female patient.
Contaminated. Shown to be a SW579 derivative (PubMed=25877200, DSMZ). Originally thought to originate from a thyroid gland follicular carcinoma metastasizing to the sternum of a 70 year old Chinese female patient.
Misidentified. Originally thought to be a colon adenocarcinoma cell line but shown to be from a Melanoma (PubMed=25926053).
Misidentified. Originally thought to be a colon adenocarcinoma cell line but shown to be from a Melanoma (PubMed=25926053).
Misidentified. Originally thought to be a colon adenocarcinoma cell line but shown to be from a Melanoma (PubMed=25926053).
Misidentified. Originally thought to be a colon adenocarcinoma cell line but shown to be from a Melanoma (PubMed=25926053).
Probably misidentified. Originally thought to be a acute monoblastic leukemia but seems to be a T-ALL cell line (PubMed=15843827). Was also said to originate from a 40 year old female patient (PubMed=6593267) but has a male STR profile.
Probably misidentified. Originally thought to be a acute monoblastic leukemia but seems to be a T-ALL cell line (PubMed=15843827). Was also said to originate from a 40 year old female patient (PubMed=6593267) but has a male STR profile.
Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
Partially contaminated. Some stocks (such as IFO50028) were contaminated by Daudi.
Partially contaminated. Some stocks (such as IFO50028) were contaminated by Daudi.
Partially contaminated. Some stocks (such as IFO50028) were contaminated by Daudi.
Partially contaminated. Some stocks (such as IFO50028) were contaminated by Daudi.
Probably misidentified. Originally thought to be a leukemia cell line but is probably a B-lymphoblastoid cell line (PubMed=12592342).
Contaminated. Shown to be a SSP-25 derivative (PubMed=16643607; PubMed=20143388). Originally thought to originate from the ascitic fluid of a 61 year old woman patient with sarcomatoid cholangiocarcinoma.
Contaminated. Shown to be a SSP-25 derivative (PubMed=16643607; PubMed=20143388). Originally thought to originate from the ascitic fluid of a 61 year old woman patient with sarcomatoid cholangiocarcinoma.
Contaminated. Shown to be a RERF-LC-A1 derivative (PubMed=16643607; PubMed=20143388).
Possibly misidentified. It is not certain that this cell line originate from a hairy cell leukemia (PubMed=22653958).
Possibly misidentified. It is not certain that this cell line originate from a hairy cell leukemia (PubMed=22653958).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be an acute myeloid leukemia cell line (PubMed=29533902).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be an acute myeloid leukemia cell line (PubMed=29533902).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be an acute myeloid leukemia cell line (PubMed=29533902).
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=10516762).
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=10516762).
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=10516762).
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=10516762).
Contaminated. Shown to be a GLAG-66 derivative (STR profile and somatic mutations from Cosmic-CLP).
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=10516762).
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=10516762).
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=10516762).
Misidentified/contaminated. Shown to be identical to MEL-Wei. This cell line was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile (PubMed=10508494; PubMed=20143388). According to DSMZ ACC-62 it is a human female cell line.
Misidentified/contaminated. Shown to be identical to MEL-Wei. This cell line was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile (PubMed=10508494; PubMed=20143388). According to DSMZ ACC-62 it is a human female cell line.
Misidentified/contaminated. Shown to be identical to MEL-Wei. This cell line was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile (PubMed=10508494; PubMed=20143388). According to DSMZ ACC-62 it is a human female cell line.
Misidentified/contaminated. Shown to be identical to MEL-Wei. This cell line was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile (PubMed=10508494; PubMed=20143388). According to DSMZ ACC-62 it is a human female cell line.
Misidentified/contaminated. Shown to be identical to MEL-Wei. This cell line was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile (PubMed=10508494; PubMed=20143388). According to DSMZ ACC-62 it is a human female cell line.
Misidentified/contaminated. Shown to be identical to MEL-Wei. This cell line was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile (PubMed=10508494; PubMed=20143388). According to DSMZ ACC-62 it is a human female cell line.
Misidentified/contaminated. Shown to be identical to MEL-Wei. This cell line was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile (PubMed=10508494; PubMed=20143388). According to DSMZ ACC-62 it is a human female cell line.
Misidentified/contaminated. Shown to be identical to MEL-Wei. This cell line was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile (PubMed=10508494; PubMed=20143388). According to DSMZ ACC-62 it is a human female cell line.
Contaminated. Shown to be a MKN74 derivative (PubMed=20143388).
Contaminated. Shown to be a MKN74 derivative (PubMed=20143388).
Contaminated. Shown to be a MKN74 derivative (PubMed=20143388).
Contaminated. Shown to be a Namalwa derivative (PubMed=19344951). Originally thought to originate from a 5 year old girl with myelodysplastic disorder.
Contaminated. Shown to be a Namalwa derivative (PubMed=19344951). Originally thought to originate from a 5 year old girl with myelodysplastic disorder.
Contaminated. Shown to be a Namalwa derivative (PubMed=19344951). Originally thought to originate from a 5 year old girl with myelodysplastic disorder.
Contaminated. Shown to be a Namalwa derivative (PubMed=19344951). Originally thought to originate from a 5 year old girl with myelodysplastic disorder.
Contaminated. Shown to be a OVCAR-8 derivative (PubMed=16504380; PubMed=20143388).
Contaminated. Shown to be a OVCAR-8 derivative (PubMed=16504380; PubMed=20143388).
Contaminated. Shown to be a OVCAR-8 derivative (PubMed=16504380; PubMed=20143388).
Contaminated. Shown to be a OVCAR-8 derivative (PubMed=16504380; PubMed=20143388).
Contaminated. Shown to be a OVCAR-8 derivative (PubMed=16504380; PubMed=20143388).
Contaminated. Shown to be a OVCAR-8 derivative (PubMed=16504380; PubMed=20143388).
Contaminated. Shown to be a OVCAR-8 derivative (PubMed=16504380; PubMed=20143388).
Contaminated. Shown to be a OVCAR-8 derivative (PubMed=16504380; PubMed=20143388).
Contaminated. Shown to be a OVCAR-8 derivative (PubMed=16504380; PubMed=20143388).
Contaminated. Shown to be a OVCAR-8 derivative (PubMed=16504380; PubMed=20143388).
Contaminated. Shown to be a OVCAR-8 derivative (PubMed=16504380; PubMed=20143388).
Contaminated. Shown to be a OVCAR-8 derivative (PubMed=16504380; PubMed=20143388).
Contaminated. Shown to be a OVCAR-8 derivative (PubMed=16504380; PubMed=20143388).
Contaminated. Shown to be a OVCAR-8 derivative (PubMed=16504380; PubMed=20143388).
Contaminated. Shown to be a OVCAR-8 derivative (PubMed=16504380; PubMed=20143388).
Contaminated. NCI-H1304 and NCI-H1870 have been shown to be identical.
Contaminated. NCI-H1304 and NCI-H1870 have been shown to be identical.
Contaminated. NCI-H1304 and NCI-H1870 have been shown to be identical.
Contaminated. NCI-H1304 and NCI-H1870 have been shown to be identical.
Contaminated. NCI-H1304 and NCI-H1870 have been shown to be identical.
Contaminated. NCI-H1304 and NCI-H1870 have been shown to be identical.
Contaminated. NCI-H1304 and NCI-H1870 have been shown to be identical.
Contaminated. The contaminant is not known. Seems to be a mixture of cell lines. Originally said to originate from a 60 year old male rectal carcinoma patient.
Contaminated. The contaminant is not known. Seems to be a mixture of cell lines. Originally said to originate from a 60 year old male rectal carcinoma patient.
Contaminated. The contaminant is not known. Seems to be a mixture of cell lines. Originally said to originate from a 60 year old male rectal carcinoma patient.
Contaminated. The contaminant is not known. Seems to be a mixture of cell lines. Originally said to originate from a 60 year old male rectal carcinoma patient.
Possibly contaminated. May be identical to OC 314 (CVCL_1616) according to STR profiling done at ICLC and to MSI data (PubMed=15677628).
Possibly contaminated. May be identical to OC 314 (CVCL_1616) according to STR profiling done at ICLC and to MSI data (PubMed=15677628).
Possibly contaminated. May be identical to OC 314 (CVCL_1616) according to STR profiling done at ICLC and to MSI data (PubMed=15677628).
Possibly contaminated. May be identical to OC 314 (CVCL_1616) according to STR profiling done at ICLC and to MSI data (PubMed=15677628).
Possibly contaminated. May be identical to OC 314 (CVCL_1616) according to STR profiling done at ICLC and to MSI data (PubMed=15677628).
Possibly contaminated. May be identical to OC 314 (CVCL_1616) according to STR profiling done at ICLC and to MSI data (PubMed=15677628).
Misidentified. Originally thought to be a high grade ovarian serous adenocarcinoma but suspected to have a upper gastrointestinal origin (PubMed=27353327).
Misidentified. Originally thought to be a high grade ovarian serous adenocarcinoma but suspected to have a upper gastrointestinal origin (PubMed=27353327).
Misidentified. Originally thought to be a high grade ovarian serous adenocarcinoma but suspected to have a upper gastrointestinal origin (PubMed=27353327).
Misidentified. Originally thought to be a high grade ovarian serous adenocarcinoma but suspected to have a upper gastrointestinal origin (PubMed=27353327).
Misidentified. Originally thought to be a high grade ovarian serous adenocarcinoma but suspected to have a upper gastrointestinal origin (PubMed=27353327).
Misidentified. Originally thought to be a high grade ovarian serous adenocarcinoma but suspected to have a upper gastrointestinal origin (PubMed=27353327).
Misidentified. Originally thought to be a high grade ovarian serous adenocarcinoma but suspected to have a upper gastrointestinal origin (PubMed=27353327).
Contaminated. Shown to be a PC-9 derivative.
Contaminated. Shown to be a PC-9 derivative.
Misidentified. From a B-cell lymphoma and not from a gastric cancer (PubMed=12226758).
Misidentified. From a B-cell lymphoma and not from a gastric cancer (PubMed=12226758).
Misidentified. Originally thought to be a rhabdomyosarcoma cell line but shown to be from an Ewing sarcoma (PubMed=17154184).
Misidentified. Originally thought to be a rhabdomyosarcoma cell line but shown to be from an Ewing sarcoma (PubMed=17154184).
Misidentified. Originally thought to be a rhabdomyosarcoma cell line but shown to be from an Ewing sarcoma (PubMed=17154184).
Misidentified. Originally thought to be a rhabdomyosarcoma cell line but shown to be from an Ewing sarcoma (PubMed=17154184).
Misidentified. Originally thought to be a rhabdomyosarcoma cell line but shown to be from an Ewing sarcoma (PubMed=17154184).
Misidentified. Originally thought to be a rhabdomyosarcoma cell line but shown to be from an Ewing sarcoma (PubMed=17154184).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line but is a B-lymphoblastoid cell line (PubMed=12592342; PubMed=20143388; PubMed=29533902).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line but is a B-lymphoblastoid cell line (PubMed=12592342; PubMed=20143388; PubMed=29533902).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line but is a B-lymphoblastoid cell line (PubMed=12592342; PubMed=20143388; PubMed=29533902).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line but is a B-lymphoblastoid cell line (PubMed=12592342; PubMed=20143388; PubMed=29533902).
Contaminated. Shown to be a SNG-II derivative (JCRB). Originally thougth to originate from the pleural effusion of a 66 year old female patient with metastatic ovarian epithelial carcinoma.
Possibly misidentified/contaminated. Shown to be identical to SBC-2 (JCRB web site and STR profile).
Possibly misidentified/contaminated. Shown to be identical to SBC-2 (JCRB web site and STR profile).
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from an urinary bladder carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from an urinary bladder carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from an urinary bladder carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from an urinary bladder carcinoma.
Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
Contaminated. Shown to be a Marcus derivative (PubMed=20143388).
Contaminated. Shown to be a Marcus derivative (PubMed=20143388).
Contaminated. Shown to be a Marcus derivative (PubMed=20143388).
Contaminated. Shown to be a RD derivative (PubMed=2650908; PubMed=2739733; PubMed=2911385; PubMed=20143388). Originally thought to originate from a 6 year old patient with medulloblastoma.
Contaminated. Shown to be a RD derivative (PubMed=2650908; PubMed=2739733; PubMed=2911385; PubMed=20143388). Originally thought to originate from a 6 year old patient with medulloblastoma.
Contaminated. Shown to be a RD derivative (PubMed=2650908; PubMed=2739733; PubMed=2911385; PubMed=20143388). Originally thought to originate from a 6 year old patient with medulloblastoma.
Contaminated. Shown to be a RD derivative (PubMed=2650908; PubMed=2739733; PubMed=2911385; PubMed=20143388). Originally thought to originate from a 6 year old patient with medulloblastoma.
Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709; PubMed=20143388).
Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709; PubMed=20143388).
Contaminated. Parent cell line (Girardi Heart) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Parent cell line (Girardi Heart) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Parent cell line (Girardi Heart) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Parent cell line (Girardi Heart) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Parent cell line (Girardi Heart) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Parent cell line (Girardi Heart) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (DSMZ ACC-227). Originally thought to originate from the malignant urinary bladder carcinoma of a 66 year old Caucasian man in 1989.
Partially contaminated. The stock formerly distributed by CLS under catalog number 300214 was contaminated. Compared to the STR values obtained by other distributors it differed from having: Amelogenin
Partially contaminated. The stock formerly distributed by CLS under catalog number 300214 was contaminated. Compared to the STR values obtained by other distributors it differed from having: Amelogenin
Partially contaminated. The stock formerly distributed by CLS under catalog number 300214 was contaminated. Compared to the STR values obtained by other distributors it differed from having: Amelogenin
Partially contaminated. The stock formerly distributed by CLS under catalog number 300214 was contaminated. Compared to the STR values obtained by other distributors it differed from having: Amelogenin
Partially contaminated. The stock formerly distributed by CLS under catalog number 300214 was contaminated. Compared to the STR values obtained by other distributors it differed from having: Amelogenin
Partially contaminated. The stock formerly distributed by CLS under catalog number 300214 was contaminated. Compared to the STR values obtained by other distributors it differed from having: Amelogenin
Partially contaminated. The stock formerly distributed by CLS under catalog number 300214 was contaminated. Compared to the STR values obtained by other distributors it differed from having: Amelogenin
Partially contaminated. The stock formerly distributed by CLS under catalog number 300214 was contaminated. Compared to the STR values obtained by other distributors it differed from having: Amelogenin
Partially contaminated. The stock formerly distributed by CLS under catalog number 300214 was contaminated. Compared to the STR values obtained by other distributors it differed from having: Amelogenin
Partially contaminated. The stock formerly distributed by CLS under catalog number 300214 was contaminated. Compared to the STR values obtained by other distributors it differed from having: Amelogenin
Contaminated. Shown to be a RPMI-8226 derivative (PubMed=20143388).
Contaminated. Shown to be a RPMI-8226 derivative (PubMed=20143388).
Contaminated. Shown to be a RPMI-8226 derivative (PubMed=20143388).
Contaminated. Shown to be a OVCAR-3 derivative (PubMed=20143388). Originally thought to originate from a 49 year old female patient with a thyroid gland papillary carcinoma.
Contaminated. Shown to be a OVCAR-3 derivative (PubMed=20143388). Originally thought to originate from a 49 year old female patient with a thyroid gland papillary carcinoma.
Contaminated. Shown to be a OVCAR-3 derivative (PubMed=20143388). Originally thought to originate from a 49 year old female patient with a thyroid gland papillary carcinoma.
Contaminated. Shown to be a OVCAR-3 derivative (PubMed=20143388). Originally thought to originate from a 49 year old female patient with a thyroid gland papillary carcinoma.
Misidentified. Originally thought to be a leukemia cell line from a patient with myelodysplastic syndrome but is a B-lymphoblastoid cell line (PubMed=10516762; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=1246601; PubMed=20143388). Originally thought to originate from a normal amnion.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=1246601; PubMed=20143388). Originally thought to originate from a normal amnion.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=1246601; PubMed=20143388). Originally thought to originate from a normal amnion.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388). Originally thought to originate from a normal amnion.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388). Originally thought to originate from a normal amnion.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388). Originally thought to originate from a normal amnion.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from embryonic intestinal cells (jejunum/ileum).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from embryonic intestinal cells (jejunum/ileum).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from embryonic intestinal cells (jejunum/ileum).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from embryonic intestinal cells (jejunum/ileum).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from embryonic intestinal cells (jejunum/ileum).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from embryonic intestinal cells (jejunum/ileum).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from embryonic intestinal cells (jejunum/ileum).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from embryonic intestinal cells (jejunum/ileum).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from embryonic intestinal cells (jejunum/ileum).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from embryonic intestinal cells (jejunum/ileum).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from embryonic intestinal cells (jejunum/ileum).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from embryonic intestinal cells (jejunum/ileum).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from embryonic intestinal cells (jejunum/ileum).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to be a lung embryonic cell line.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to be a lung embryonic cell line.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to be a lung embryonic cell line.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=6451928; PubMed=20143388). Originally thought to originate from cells of the amniotic sac of Susan Hayflick, the daughter of Leonard Hayflick.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=6451928; PubMed=20143388). Originally thought to originate from cells of the amniotic sac of Susan Hayflick, the daughter of Leonard Hayflick.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=6451928; PubMed=20143388). Originally thought to originate from cells of the amniotic sac of Susan Hayflick, the daughter of Leonard Hayflick.
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative (PubMed=20143388).
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative (PubMed=20143388).
Contaminated. Shown to be a DU145 derivative (PubMed=10508494; PubMed=20143388).
Contaminated. Shown to be a DU145 derivative (PubMed=10508494; PubMed=20143388).
Contaminated. Shown to be a DU145 derivative (PubMed=10508494; PubMed=20143388).
Contaminated. Shown to be a RD-ES derivative (DSMZ ACC-268). Originally thought to originate from a benign giant cell tumor excised from a 35 year old female patient.
Contaminated. Shown to be a RD-ES derivative (DSMZ ACC-268). Originally thought to originate from a benign giant cell tumor excised from a 35 year old female patient.
Partially contaminated. Some stocks are contaminated by COLO 704 (CVCL_AV69).
Partially contaminated. Some stocks are contaminated by COLO 704 (CVCL_AV69).
Partially contaminated. Some stocks are contaminated by COLO 704 (CVCL_AV69).
Partially contaminated. Some stocks are contaminated by COLO 704 (CVCL_AV69).
Partially contaminated. Some stocks are contaminated by COLO 704 (CVCL_AV69).
Contaminated. Shown to be a RPMI-8226 derivative (ECACC). Originally thought to originate from the peripheral blood of a 57 year old female patient with chronic myelogenous leukemia.
Contaminated. Shown to be a RPMI-8226 derivative (ECACC). Originally thought to originate from the peripheral blood of a 57 year old female patient with chronic myelogenous leukemia.
Contaminated. Shown to be a COLO 800 derivative (PubMed=10508494; PubMed=20143388).
Contaminated. Shown to be a COLO 800 derivative (PubMed=10508494; PubMed=20143388).
Contaminated. Shown to be a COLO 800 derivative (PubMed=10508494; PubMed=20143388).
Contaminated. The STR profile is identical to that of the NCI-H460 cell line. Contamination confirmed by personal communication of Linnebacher M. Originally thought to originate from the resection of the brain metastasis of a 47 year-old female Caucasian patient suffering from a non-small cell lung carcinoma.
Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
Misidentified. Originally thought (PubMed=19584161) to be a A-172 (CVCL_0131) derivative but shown to be a U-251MG derivative (DOI=10.1158/1078-0432.CCR-13-1821).
Misidentified. Originally thought (PubMed=19584161) to be a A-172 (CVCL_0131) derivative but shown to be a U-251MG derivative (DOI=10.1158/1078-0432.CCR-13-1821).
Misidentified. Originally thought (PubMed=19584161) to be a A-172 (CVCL_0131) derivative but shown to be a U-251MG derivative (DOI=10.1158/1078-0432.CCR-13-1821).
Contaminated. Shown to be a Jiyoye derivative (PubMed=4736620).
Contaminated. Shown to be a Jiyoye derivative (PubMed=4736620).
Contaminated. Shown to be a Jiyoye derivative (PubMed=4736620).
Contaminated. Parent cell line (F-137) has been shown to be a Jiyoye derivative.
Contaminated. Shown to be a K-562 derivative (PubMed=19344951).
Contaminated. Parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative (PubMed=21868764).
Contaminated. Parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative (PubMed=21868764).
Contaminated. Parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative.
Contaminated. Parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative.
Contaminated. Parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative (PubMed=21868764).
Contaminated. Shown to be a UM-SCC-1 derivative (PubMed=21868764).
Contaminated. Shown to be a UM-SCC-1 derivative (PubMed=21868764).
Misidentified/contaminated. Shown not to be derived from UM-UC-3, its origin is unknow (PubMed=19375735; PubMed=20143388).
Contaminated. Shown to be a HCT 15 derivative (PubMed=24046071). Originally thought to originate from an osteosarcoma.
Contaminated. Shown to be a HCT 15 derivative (PubMed=24046071). Originally thought to originate from an osteosarcoma.
Contaminated. Shown to be a HCT 15 derivative (PubMed=24046071). Originally thought to originate from an osteosarcoma.
Contaminated. Shown to be a Hep-G2 derivative (PubMed=12619888; PubMed=20143388). Originally thought to originate from SV40-transformed normal liver cells.
Contaminated. Shown to be a Hep-G2 derivative (PubMed=12619888; PubMed=20143388). Originally thought to originate from SV40-transformed normal liver cells.
Contaminated. Shown to be a Hep-G2 derivative (PubMed=12619888; PubMed=20143388). Originally thought to originate from SV40-transformed normal liver cells.
Contaminated. Shown to be a Hep-G2 derivative (PubMed=12619888; PubMed=20143388). Originally thought to originate from SV40-transformed normal liver cells.
Contaminated. Shown to be a Hep-G2 derivative (PubMed=12619888; PubMed=20143388). Originally thought to originate from SV40-transformed normal liver cells.
Contaminated. Shown to be a Hep-G2 derivative (PubMed=12619888; PubMed=20143388). Originally thought to originate from SV40-transformed normal liver cells.
Contaminated. Shown to be a Hep-G2 derivative (PubMed=12619888; PubMed=20143388). Originally thought to originate from SV40-transformed normal liver cells.
Contaminated. Shown to be a Hep-G2 derivative (PubMed=12619888; PubMed=20143388). Originally thought to originate from SV40-transformed normal liver cells.
Contaminated. Parent cell line (H7D7B) has been shown to be a Hep-G2 derivative (PubMed=12619888).
Contaminated. Parent cell line (H7D7B) has been shown to be a Hep-G2 derivative (PubMed=12619888).
Contaminated. Parent cell line (H7D7B) has been shown to be a Hep-G2 derivative (PubMed=12619888).
Contaminated. Parent cell line (H7D7B) has been shown to be a Hep-G2 derivative (PubMed=12619888).
Contaminated. Shown to be a PA-1 derivative (PubMed=22710073).
Contaminated. Parent cell line (222) has been shown to be a PA-1 derivative.
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
Misidentified/contaminated. Supposed to be isogenic with PCI-22B (CVCL_1T57) but does not have the same STR profile and are therefore not originating from the same individual (PubMed=21868764).
Misidentified/contaminated. Supposed to be isogenic with PCI-22B (CVCL_1T57) but does not have the same STR profile and are therefore not originating from the same individual (PubMed=21868764).
Misidentified/contaminated. Supposed to be isogenic with PCI-22A (CVCL_1T56) but does not have the same STR profile and are therefore not originating from the same individual (PubMed=21868764).
Misidentified/contaminated. Supposed to be isogenic with PCI-22A (CVCL_1T56) but does not have the same STR profile and are therefore not originating from the same individual (PubMed=21868764).
Contaminated. Shown to be a HeLa derivative (PubMed=22949886).
Contaminated. Shown to be a T24 derivative (DOI=10.11418/jtca1981.18.4_329; PubMed=10508494; PubMed=12197766; PubMed=20143388). Originally thought to originate from endothelial cells obtained from the umbilical vein of a healthy donor.
Contaminated. Shown to be a T24 derivative (DOI=10.11418/jtca1981.18.4_329; PubMed=10508494; PubMed=12197766; PubMed=20143388). Originally thought to originate from endothelial cells obtained from the umbilical vein of a healthy donor.
Contaminated. Shown to be a T24 derivative (DOI=10.11418/jtca1981.18.4_329; PubMed=10508494; PubMed=12197766; PubMed=20143388). Originally thought to originate from endothelial cells obtained from the umbilical vein of a healthy donor.
Contaminated. Shown to be a T24 derivative (DOI=10.11418/jtca1981.18.4_329; PubMed=10508494; PubMed=12197766; PubMed=20143388). Originally thought to originate from endothelial cells obtained from the umbilical vein of a healthy donor.
Contaminated. Shown to be a T24 derivative (DOI=10.11418/jtca1981.18.4_329; PubMed=10508494; PubMed=12197766; PubMed=20143388). Originally thought to originate from endothelial cells obtained from the umbilical vein of a healthy donor.
Contaminated. Shown to be a T24 derivative (DOI=10.11418/jtca1981.18.4_329; PubMed=10508494; PubMed=12197766; PubMed=20143388). Originally thought to originate from endothelial cells obtained from the umbilical vein of a healthy donor.
Contaminated. Shown to be a U-343MGa derivative (PubMed=22570425). Originally thought to originate from the brain of a 55 year old patient with a mixed astro-oligodendroglioma (grade II/III).
Contaminated. Shown to be a U-343MGa derivative (PubMed=22570425). Originally thought to originate from the brain of a 55 year old patient with a mixed astro-oligodendroglioma (grade II/III).
Contaminated. Shown to be a U-937 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a U-937 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388).
Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Shown to be a HPAC derivative (PubMed=20143388). Originally thought to originate from a 74 year old male patient with a moderately differentiated adenocarcinoma of the head of the pancreas.
Contaminated. Shown to be a HPAC derivative (PubMed=20143388). Originally thought to originate from a 74 year old male patient with a moderately differentiated adenocarcinoma of the head of the pancreas.
Contaminated. Shown to be a HPAC derivative (PubMed=20143388). Originally thought to originate from a 74 year old male patient with a moderately differentiated adenocarcinoma of the head of the pancreas.
Contaminated. Shown to be a HPAC derivative (PubMed=20143388). Originally thought to originate from a 74 year old male patient with a moderately differentiated adenocarcinoma of the head of the pancreas.
Contaminated. Shown to be a MCF-7 derivative (PubMed=20143388).
Contaminated. Shown to be a MCF-7 derivative (PubMed=20143388).
Partially contaminated. The RCB/Riken RCB1982 stock was contaminated and was replaced by RCB4561 which originates from DSMZ ACC-36. On the basis of STR profile, the version at TKG (TKG 0385) seems to be identical or closely related to the RCB1962 contaminated stock.
Partially contaminated. The RCB/Riken RCB1982 stock was contaminated and was replaced by RCB4561 which originates from DSMZ ACC-36. On the basis of STR profile, the version at TKG (TKG 0385) seems to be identical or closely related to the RCB1962 contaminated stock.
Partially contaminated. The RCB/Riken RCB1982 stock was contaminated and was replaced by RCB4561 which originates from DSMZ ACC-36. On the basis of STR profile, the version at TKG (TKG 0385) seems to be identical or closely related to the RCB1962 contaminated stock.
Partially contaminated. The RCB/Riken RCB1982 stock was contaminated and was replaced by RCB4561 which originates from DSMZ ACC-36. On the basis of STR profile, the version at TKG (TKG 0385) seems to be identical or closely related to the RCB1962 contaminated stock.
Contaminated. Shown to be a LS174T derivative.
Contaminated. Shown to be a LS174T derivative.
Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a 38 year old female patient with acute nonlymphocytic leukemia.
Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a 38 year old female patient with acute nonlymphocytic leukemia.
Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a 38 year old female patient with acute nonlymphocytic leukemia.
Contaminated. Shown to be a KE-37 derivative (PubMed=20143388). Originally thought to originate from the peripheral blood of a 61 year old male patient with T cell chronic lymphocytic leukemia.
Contaminated. Shown to be a KE-37 derivative (PubMed=20143388). Originally thought to originate from the peripheral blood of a 61 year old male patient with T cell chronic lymphocytic leukemia.
Contaminated. Shown to be a K-562 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a K-562 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388).
Misidentified/contaminated. Shown to be a U-251MG derivative. This cell line is not the original astrocytoma cell line established in 1973 at the University of Uppsala. See U-373MG Uppsala (CVCL_2818) for the original U-373MG cell line.
Misidentified/contaminated. Shown to be a U-251MG derivative. This cell line is not the original astrocytoma cell line established in 1973 at the University of Uppsala. See U-373MG Uppsala (CVCL_2818) for the original U-373MG cell line.
Misidentified/contaminated. Shown to be a U-251MG derivative. This cell line is not the original astrocytoma cell line established in 1973 at the University of Uppsala. See U-373MG Uppsala (CVCL_2818) for the original U-373MG cell line.
Misidentified/contaminated. Shown to be a U-251MG derivative. This cell line is not the original astrocytoma cell line established in 1973 at the University of Uppsala. See U-373MG Uppsala (CVCL_2818) for the original U-373MG cell line.
Misidentified/contaminated. Shown to be a U-251MG derivative. This cell line is not the original astrocytoma cell line established in 1973 at the University of Uppsala. See U-373MG Uppsala (CVCL_2818) for the original U-373MG cell line.
Misidentified/contaminated. Shown to be a U-251MG derivative. This cell line is not the original astrocytoma cell line established in 1973 at the University of Uppsala. See U-373MG Uppsala (CVCL_2818) for the original U-373MG cell line.
Misidentified/contaminated. Shown to be a U-251MG derivative. This cell line is not the original astrocytoma cell line established in 1973 at the University of Uppsala. See U-373MG Uppsala (CVCL_2818) for the original U-373MG cell line.
Misidentified/contaminated. Shown to be a U-251MG derivative. This cell line is not the original astrocytoma cell line established in 1973 at the University of Uppsala. See U-373MG Uppsala (CVCL_2818) for the original U-373MG cell line.
Misidentified/contaminated. Shown to be a U-251MG derivative. This cell line is not the original astrocytoma cell line established in 1973 at the University of Uppsala. See U-373MG Uppsala (CVCL_2818) for the original U-373MG cell line.
Misidentified/contaminated. Shown to be a U-251MG derivative. This cell line is not the original astrocytoma cell line established in 1973 at the University of Uppsala. See U-373MG Uppsala (CVCL_2818) for the original U-373MG cell line.
Misidentified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be a T lymphoblastic lymphoma (PubMed=29533902).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be a T lymphoblastic lymphoma (PubMed=29533902).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be a T lymphoblastic lymphoma (PubMed=29533902).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be a T lymphoblastic lymphoma (PubMed=29533902).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be a T lymphoblastic lymphoma (PubMed=29533902).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from normal heart cells.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from normal heart cells.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from normal heart cells.
Contaminated. Shown to be a HeLa derivative (PubMed=566722; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=566722; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=566722; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=566722; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=566722; PubMed=20143388).
Partially contaminated. The ICLC stock (now discontinued) was found to be contaminated, probably by U-251MG (CVCL_0021).
Partially contaminated. The ICLC stock (now discontinued) was found to be contaminated, probably by U-251MG (CVCL_0021).
Partially contaminated. The ICLC stock (now discontinued) was found to be contaminated, probably by U-251MG (CVCL_0021).
Partially contaminated. The ICLC stock (now discontinued) was found to be contaminated, probably by U-251MG (CVCL_0021).
Partially contaminated. The ICLC stock (now discontinued) was found to be contaminated, probably by U-251MG (CVCL_0021).
Partially contaminated. The ICLC stock (now discontinued) was found to be contaminated, probably by U-251MG (CVCL_0021).
Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to be a clone of MRC-5.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=6823318; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=6823318; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=6823318; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=6823318; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=6823318; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=6823318; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=6823318; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=6823318; PubMed=20143388).
Contaminated. Shown to be a PSN1 derivative (PubMed=25877200). Originally thought to originate from the thorax of a 36 year old male melanoma patient with skin metastases.
Contaminated. Shown to be a PSN1 derivative (PubMed=25877200). Originally thought to originate from the thorax of a 36 year old male melanoma patient with skin metastases.
Contaminated. Shown to be a Jiyoye derivative (PubMed=10516762; PubMed=12592342; PubMed=20143388). Originally thought to originate from a plasma cell myeloma.
Contaminated. Shown to be a Jiyoye derivative (PubMed=10516762; PubMed=12592342; PubMed=20143388). Originally thought to originate from a plasma cell myeloma.
Contaminated. Shown to be a Jiyoye derivative (PubMed=10516762; PubMed=12592342; PubMed=20143388). Originally thought to originate from a plasma cell myeloma.
Contaminated. Shown to be a Jiyoye derivative (PubMed=10516762; PubMed=12592342; PubMed=20143388). Originally thought to originate from a plasma cell myeloma.
Contaminated. Shown to be a Jiyoye derivative (PubMed=10516762; PubMed=12592342; PubMed=20143388). Originally thought to originate from a plasma cell myeloma.
Contaminated. Shown to be a Jiyoye derivative (PubMed=10516762; PubMed=12592342; PubMed=20143388). Originally thought to originate from a plasma cell myeloma.
Contaminated. Shown to be a Jiyoye derivative (PubMed=10516762; PubMed=12592342; PubMed=20143388). Originally thought to originate from a plasma cell myeloma.
Contaminated. Shown to be a Jiyoye derivative (PubMed=10516762; PubMed=12592342; PubMed=20143388). Originally thought to originate from a plasma cell myeloma.
Contaminated. Shown to be a HeLa derivative (PubMed=20143388; PubMed=29923277). Originally thought to originate from a 54 year old male irradiated submandibular salivary gland.
Contaminated. Shown to be a HeLa derivative (PubMed=20143388; PubMed=29923277). Originally thought to originate from a 54 year old male irradiated submandibular salivary gland.
Misidentified. Grand-parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Contaminated. Shown to be a GLAG-66 derivative (PubMed=19087340; PubMed=20143388).
Possibly misidentified. It is not certain that this cell line originate from a metastatic melanoma. Lacks the expression of three protein markers: S100, HMB-45 and Melan-A commonly found in melanoma cell lines (PubMed=27087056).
Possibly misidentified. It is not certain that this cell line originate from a metastatic melanoma. Lacks the expression of three protein markers: S100, HMB-45 and Melan-A commonly found in melanoma cell lines (PubMed=27087056).
Contaminated. Presence of a second cell line in earliest stock not picked up due to low level of contamination (CBA).
Contaminated. Presence of a second cell line in earliest stock not picked up due to low level of contamination (CBA).
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin.
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin.
Partially contaminated. Two different lots formerly distributed by NIH-ARP; 13 P7 3/9/92 and 150048; were shown not to be authentic MT-4 (PubMed=9261343; PubMed=31554688).
Partially contaminated. Two different lots formerly distributed by NIH-ARP; 13 P7 3/9/92 and 150048; were shown not to be authentic MT-4 (PubMed=9261343; PubMed=31554688).
Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative (PubMed=2739733; PubMed=20143388).
Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative (PubMed=2739733; PubMed=20143388).
Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative (PubMed=2739733; PubMed=20143388).
Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative (PubMed=2739733; PubMed=20143388).
Contaminated. Shown to be a HT-29 derivative (PubMed=3472642; PubMed=20143388). Originally thought to originate from a 78 year old female patient primary adenocarcinoma of the rectosigmoid colon.
Contaminated. Shown to be a HT-29 derivative (PubMed=3472642; PubMed=20143388). Originally thought to originate from a 78 year old female patient primary adenocarcinoma of the rectosigmoid colon.
Contaminated. Shown to be a HT-29 derivative (PubMed=3472642; PubMed=20143388). Originally thought to originate from a 78 year old female patient primary adenocarcinoma of the rectosigmoid colon.
Contaminated. Shown to be a HT-29 derivative (PubMed=3472642; PubMed=20143388). Originally thought to originate from a 78 year old female patient primary adenocarcinoma of the rectosigmoid colon.
Contaminated. Shown to be a HT-29 derivative (PubMed=3472642; PubMed=20143388). Originally thought to originate from a 78 year old female patient primary adenocarcinoma of the rectosigmoid colon.
Contaminated. Shown to be a HT-29 derivative (PubMed=3472642; PubMed=20143388). Originally thought to originate from a 78 year old female patient primary adenocarcinoma of the rectosigmoid colon.
Contaminated. Shown to be a HT-29 derivative (PubMed=3472642; PubMed=20143388). Originally thought to originate from a 78 year old female patient primary adenocarcinoma of the rectosigmoid colon.
Contaminated. Shown to be a HT-29 derivative (PubMed=3472642; PubMed=20143388). Originally thought to originate from a 78 year old female patient primary adenocarcinoma of the rectosigmoid colon.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
Partially contaminated. Some JCRB stocks were found to be from mouse (PubMed=20143388). Stock bought in 2013 was shown to be human by exome sequencing (personal communication of Rebouissou S.).
Partially contaminated. Some JCRB stocks were found to be from mouse (PubMed=20143388). Stock bought in 2013 was shown to be human by exome sequencing (personal communication of Rebouissou S.).
Partially contaminated. Some JCRB stocks were found to be from mouse (PubMed=20143388). Stock bought in 2013 was shown to be human by exome sequencing (personal communication of Rebouissou S.).
Contaminated. Shown to be a Ca9-22 derivative (PubMed=20143388). Originally thought to originate from a 72 year old female patient with a lower-gingiva squamous cell carcinoma.
Contaminated. Shown to be a Ca9-22 derivative (PubMed=20143388). Originally thought to originate from a 72 year old female patient with a lower-gingiva squamous cell carcinoma.
Contaminated. Shown to be a Ca9-22 derivative (PubMed=20143388). Originally thought to originate from a 72 year old female patient with a lower-gingiva squamous cell carcinoma.
Contaminated. Shown to be a U-251MG derivative (PubMed=20143388; PubMed=22570425). Was originally thought to originate from a 66 year old male gliosarcoma patient.
Contaminated. Shown to be a U-251MG derivative (PubMed=20143388; PubMed=22570425). Was originally thought to originate from a 66 year old male gliosarcoma patient.
Contaminated. Shown to be a U-251MG derivative (PubMed=20143388; PubMed=22570425). Was originally thought to originate from a 66 year old male gliosarcoma patient.
Contaminated. Shown to be a ZR-75-1 derivative (PubMed=23136038). Originally thought to originate from the primary breast carcinoma tissue of a 55 year old woman patient.
Contaminated. Shown to be a ZR-75-1 derivative (PubMed=23136038). Originally thought to originate from the primary breast carcinoma tissue of a 55 year old woman patient.
Contaminated. Parent cell line (YMB-1) has been shown to be a ZR-75-1 derivative (PubMed=23136038).
Contaminated. Parent cell line (YMB-1) has been shown to be a ZR-75-1 derivative (PubMed=23136038).
Contaminated. Parent cell line (YMB-1) has been shown to be a ZR-75-1 derivative (PubMed=23136038).
Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a Hutu 80 derivative (see JCRB web site).
Contaminated. Shown to be a Hutu 80 derivative (see JCRB web site).
Contaminated. Shown to be a Hutu 80 derivative (see JCRB web site).
On the basis of the STR profile the cell line at ATCC (no longer available) and the one at JCRB are not the same.
On the basis of the STR profile the cell line at ATCC (no longer available) and the one at JCRB are not the same.
On the basis of the STR profile the cell line at ATCC (no longer available) and the one at JCRB are not the same.
Contaminated. Grand-parent cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Grand-parent cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Grand-parent cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Shown to be a T24 derivative (DOI=10.11418/jtca1981.18.4_329; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (DOI=10.11418/jtca1981.18.4_329; PubMed=20143388).
Contaminated. Shown to be a Flow3000 derivative.
Contaminated. Shown to be a Flow3000 derivative.
Contaminated. Shown to be a Flow3000 derivative.
Contaminated. HEC-155 and HEC-180 have been shown to be identical (PubMed=20143388). Originally thought to originate from a 56 year old female patient with primary endometrial cancer.
Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Parent cell line (HSG) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=12592342; PubMed=20143388). Originally thought to originate from a 25 year old female patient with acute monocytic leukemia.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=12592342; PubMed=20143388). Originally thought to originate from a 25 year old female patient with acute monocytic leukemia.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=12592342; PubMed=20143388). Originally thought to originate from a 25 year old female patient with acute monocytic leukemia.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=12592342; PubMed=20143388). Originally thought to originate from a 25 year old female patient with acute monocytic leukemia.
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=12592342; PubMed=20143388). Originally thought to originate from a 25 year old female patient with acute monocytic leukemia.
Misidentified. Originally thought to be a myeloma cell line and to be a sister line to KMS-21-PE (CVCL_A445) but this does not seem to be the case (PubMed=12592342; PubMed=20143388).
Misidentified. Originally thought to be a myeloma cell line and to be a sister line to KMS-21-PE (CVCL_A445) but this does not seem to be the case (PubMed=12592342; PubMed=20143388).
Misidentified. Originally thought to be a myeloma cell line and to be a sister line to KMS-21-PE (CVCL_A445) but this does not seem to be the case (PubMed=12592342; PubMed=20143388).
Contaminated. Parent cell line (WiDr) had been shown to be a HT-29 derivative.
Contaminated. Shown to be a K-562 derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from the bone marrow of 46 year old male patient suffering from acute myeloid leukemia.
Contaminated. Shown to be a K-562 derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from the bone marrow of 46 year old male patient suffering from acute myeloid leukemia.
Contaminated. Shown to be a K-562 derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from the bone marrow of 46 year old male patient suffering from acute myeloid leukemia.
Contaminated. Shown to be a PANC-1 derivative.
Contaminated. Shown to be a PANC-1 derivative.
Contaminated. Shown to be a PANC-1 derivative.
Contaminated. Shown to be a PANC-1 derivative.
Contaminated. Shown to be a PANC-1 derivative.
Contaminated. Parent cell line (KP-1N) has been shown to be a PANC-1 derivative.
Contaminated. Parent cell line (KP-1N) has been shown to be a PANC-1 derivative.
Contaminated. Parent cell line (KP-1N) has been shown to be a PANC-1 derivative.
Contaminated. Parent cell line (KP-1N) has been shown to be a PANC-1 derivative.
Contaminated. Parent cell line (KP-1N) has been shown to be a PANC-1 derivative.
Contaminated. Shown to be a Raji derivative (PubMed=20143388).
Contaminated. Shown to be a Raji derivative (PubMed=20143388).
Contaminated. Shown to be a Raji derivative (PubMed=20143388).
Contaminated. Shown to be a Raji derivative (PubMed=20143388).
Contaminated. Shown to be a OVSAYO derivative (PubMed=20143388).
Contaminated. Shown to be a WI-38 derivative (PubMed=20143388). Originally thought to originate from the skin fibroblasts of a 29 year old female Werner syndrome patient.
Contaminated. Shown to be a WI-38 derivative (PubMed=20143388). Originally thought to originate from the skin fibroblasts of a 29 year old female Werner syndrome patient.
Contaminated. Shown to be a WI-38 derivative (PubMed=20143388). Originally thought to originate from the skin fibroblasts of a 29 year old female Werner syndrome patient.
Contaminated. Shown to be a WI-38 derivative (PubMed=20143388). Originally thought to originate from the skin fibroblasts of a 29 year old female Werner syndrome patient.
Contaminated. Shown to be a SK-MES-1 derivative (PubMed=23136038).
Contaminated. Shown to be a SK-MES-1 derivative (PubMed=23136038).
Contaminated. Shown to be a SK-MES-1 derivative (PubMed=23136038).
Contaminated. Shown to be a SK-MES-1 derivative (PubMed=23136038).
Contaminated. Shown to be a SK-MES-1 derivative (PubMed=23136038).
Contaminated. Shown to be a SK-MES-1 derivative (PubMed=23136038).
Contaminated. Shown to be a Marcus derivative (PubMed=20143388). Originally thought to originate from a lung carcinoma.
Contaminated. Shown to be a Marcus derivative (PubMed=20143388). Originally thought to originate from a lung carcinoma.
Contaminated. Shown to be a Marcus derivative (PubMed=20143388). Originally thought to originate from a lung carcinoma.
Contaminated. Shown to be a Marcus derivative (PubMed=20143388). Originally thought to originate from a lung carcinoma.
Contaminated. Shown to be a Marcus derivative (PubMed=20143388). Originally thought to originate from a lung carcinoma.
Contaminated. Shown to be a Marcus derivative (PubMed=20143388). Originally thought to originate from a lung carcinoma.
Contaminated. Shown to be a SNG-II derivative. Originally thought to originate from a 62 year old female patient with ovarian mucinous cystadenocarcinoma.
Contaminated. Shown to be a SNG-II derivative. Originally thought to originate from a 62 year old female patient with ovarian mucinous cystadenocarcinoma.
Contaminated. Shown to be a TCS derivative (PubMed=16643607; PubMed=20143388). Originally thought to originate from a 34 year old patient with uterine cervical adenocarcinoma.
Contaminated. Shown to be a IHH-4 derivative (PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (CCRID; PubMed=26116706; PubMed=28851942). Originally thought to be a gastric adenocarcinoma.
Contaminated. Shown to be a HeLa derivative (CCRID; PubMed=26116706; PubMed=28851942). Originally thought to be a gastric adenocarcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a 32 year old female patient with a lung adenocarcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a 32 year old female patient with a lung adenocarcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a 32 year old female patient with a lung adenocarcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a 32 year old female patient with a lung adenocarcinoma.
Misidentified. Originally thought to be a mucinous gastric adenocarcinoma cell line from a 52 year old male patient but is a B-lymphoblastoid cell line (DSMZ; PubMed=30285677).
Misidentified. Originally thought to be a mucinous gastric adenocarcinoma cell line from a 52 year old male patient but is a B-lymphoblastoid cell line (DSMZ; PubMed=30285677).
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Contaminated. Shown to be a M14 derivative (PubMed=28940260). Originally thought to originate from a female patient with metastatic uveal melanoma.
Contaminated. Shown to be a M14 derivative (PubMed=28940260). Originally thought to originate from a female patient with metastatic uveal melanoma.
Contaminated. Shown to be a M14 derivative (PubMed=28940260). Originally thought to originate from a female patient with metastatic uveal melanoma.
Contaminated. Shown to be a M14 derivative (PubMed=28940260). Originally thought to originate from a female patient with metastatic uveal melanoma.
Misidentified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. From a B-cell lymphoma and not from a gastric cancer (PubMed=12226758).
Misidentified. From a B-cell lymphoma and not from a gastric cancer (PubMed=12226758).
Partially contaminated. Some stocks were contaminated by pig LLC-PK1 (PubMed=14505435; PubMed=20143388).
Partially contaminated. Some stocks were contaminated by pig LLC-PK1 (PubMed=14505435; PubMed=20143388).
Partially contaminated. Some stocks were contaminated by pig LLC-PK1 (PubMed=14505435; PubMed=20143388).
Partially contaminated. Some stocks were contaminated by pig LLC-PK1 (PubMed=14505435; PubMed=20143388).
Partially contaminated. Some stocks were contaminated by pig LLC-PK1 (PubMed=14505435; PubMed=20143388).
Partially contaminated. Some stocks were contaminated by pig LLC-PK1 (PubMed=14505435; PubMed=20143388).
Contaminated. From its STR profile this cell line seems to be a U-937 derivative.
Contaminated. Shown to be a SW480 derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 70 year old female patient with a metastatic breast carcinoma.
Contaminated. Shown to be a SW480 derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 70 year old female patient with a metastatic breast carcinoma.
Contaminated. Shown to be a SW480 derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 70 year old female patient with a metastatic breast carcinoma.
Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
Contaminated. Shown to be a M14 derivative (ICLAC). Originally thought to originate from a female melanoma patient.
Contaminated. Shown to be a M14 derivative (ICLAC). Originally thought to originate from a female melanoma patient.
Contaminated. Shown to be a M14 derivative (ICLAC). Originally thought to originate from a female melanoma patient.
Contaminated. Shown to be a M14 derivative (ICLAC). Originally thought to originate from a female melanoma patient.
Contaminated. Shown to be a M14 derivative (ICLAC). Originally thought to originate from a female melanoma patient.
Contaminated. Shown to be a LN-992 derivative (PubMed=22570425).
Contaminated. Shown to be a LN-992 derivative (PubMed=22570425).
Contaminated. Shown to be a LN-992 derivative (PubMed=22570425).
Contaminated. Shown to be a LN-444 derivative (PubMed=22570425). Originally thought to originate from a 66 year old male patient with a glioblastoma.
Contaminated. Shown to be a LN-444 derivative (PubMed=22570425). Originally thought to originate from a 66 year old male patient with a glioblastoma.
Contaminated. Shown to be a LN-444 derivative (PubMed=22570425). Originally thought to originate from a 66 year old male patient with a glioblastoma.
Contaminated. NCI-H157 and NCI-H1264 have been shown to be identical.
Contaminated. NCI-H157 and NCI-H1264 have been shown to be identical.
Contaminated. NCI-H157 and NCI-H1264 have been shown to be identical.
Probably contaminated. The STR profile is identical to that of the NCI-H322 cell line. Originally thought to originate from a large cell lung carcinoma.
Probably contaminated. The STR profile is identical to that of the NCI-H322 cell line. Originally thought to originate from a large cell lung carcinoma.
Probably contaminated. The STR profile is identical to that of the NCI-H322 cell line. Originally thought to originate from a large cell lung carcinoma.
Misidentified/contaminated. Shown to be identical to MEL-Ho. This cell line was reported to be isogenic with LCL-Wei (CVCL_1869) but it does not have the same STR profile (PubMed=10508494; PubMed=20143388).
Misidentified/contaminated. Shown to be identical to MEL-Ho. This cell line was reported to be isogenic with LCL-Wei (CVCL_1869) but it does not have the same STR profile (PubMed=10508494; PubMed=20143388).
Misidentified/contaminated. Shown to be identical to MEL-Ho. This cell line was reported to be isogenic with LCL-Wei (CVCL_1869) but it does not have the same STR profile (PubMed=10508494; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4472134; PubMed=20143388). Originally thought to originate from a 29 year old male patient with subacute monocytic leukemia.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4472134; PubMed=20143388). Originally thought to originate from a 29 year old male patient with subacute monocytic leukemia.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4472134; PubMed=20143388). Originally thought to originate from a 29 year old male patient with subacute monocytic leukemia.
Contaminated. Shown to be a T24 derivative (PubMed=11522622; PubMed=20143388). Originally thought to originate from a 73 year old male patient with prostate carcinoma.
Contaminated. Shown to be a T24 derivative (PubMed=11522622; PubMed=20143388). Originally thought to originate from a 73 year old male patient with prostate carcinoma.
Contaminated. Shown to be a T24 derivative (PubMed=11522622; PubMed=20143388). Originally thought to originate from a 73 year old male patient with prostate carcinoma.
Contaminated. Shown to be a T24 derivative (PubMed=11522622; PubMed=20143388). Originally thought to originate from a 73 year old male patient with prostate carcinoma.
Contaminated. Shown to be a T24 derivative (PubMed=11522622; PubMed=20143388). Originally thought to originate from a prostate carcinoma.
Contaminated. Shown to be a T24 derivative (PubMed=11522622; PubMed=20143388). Originally thought to originate from a prostate carcinoma.
Possibly misidentified/contaminated. Reported by PubMed=11787853 to contain the same HPV18 sequences as the cervix carcinoma cell line C-4-I (CVCL_2253) and to lack mutations in KRAS, TP53, CDKN2 and DPC4 often found in pancreatic adenocarcinoma.
Possibly misidentified/contaminated. Reported by PubMed=11787853 to contain the same HPV18 sequences as the cervix carcinoma cell line C-4-I (CVCL_2253) and to lack mutations in KRAS, TP53, CDKN2 and DPC4 often found in pancreatic adenocarcinoma.
Possibly misidentified/contaminated. Reported by PubMed=11787853 to contain the same HPV18 sequences as the cervix carcinoma cell line C-4-I (CVCL_2253) and to lack mutations in KRAS, TP53, CDKN2 and DPC4 often found in pancreatic adenocarcinoma.
Partially contaminated. Some stocks (such as RCB1019) were contaminated by T3M-1 (PubMed=20143388).
Partially contaminated. Some stocks (such as RCB1019) were contaminated by T3M-1 (PubMed=20143388).
Misidentified/contaminated. Originally thought to be of Chlorocebus aethiops origin but found to be a human HeLa derivative (PubMed=14505435; PubMed=20143388).
Misidentified/contaminated. Originally thought to be of Chlorocebus aethiops origin but found to be a human HeLa derivative (PubMed=14505435; PubMed=20143388).
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=20143388).
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=20143388).
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=20143388).
Contaminated. Shown to be a HEL derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388). Originally thought to originate from the peripheral blood of a 57 year old male patient with megakaryoblastic leukemia.
Contaminated. Shown to be a HEL derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388). Originally thought to originate from the peripheral blood of a 57 year old male patient with megakaryoblastic leukemia.
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=16643607; PubMed=20143388). Originally thought to originate from a casein-producing breast cell line. In addition contains SV40 genomic sequence while the cell line was deemed to be spontaneously immortalized.
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=16643607; PubMed=20143388). Originally thought to originate from a casein-producing breast cell line. In addition contains SV40 genomic sequence while the cell line was deemed to be spontaneously immortalized.
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=16643607; PubMed=20143388). Originally thought to originate from a casein-producing breast cell line. In addition contains SV40 genomic sequence while the cell line was deemed to be spontaneously immortalized.
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=20143388).
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=20143388).
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=20143388).
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=20143388). In addition according to PubMed=8806092 it is supposed to be established from the same patient as NCI-H1618 (CVCL_1480) but the STR profile is different.
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=20143388). In addition according to PubMed=8806092 it is supposed to be established from the same patient as NCI-H1618 (CVCL_1480) but the STR profile is different.
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=20143388). In addition according to PubMed=8806092 it is supposed to be established from the same patient as NCI-H1618 (CVCL_1480) but the STR profile is different.
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin.
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin.
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin.
Partially misidentified. The stock formerly distributed by ATCC and CCRID was misidentified and was actually DU145 (CVCL_0105). This is not the case of the original stock from Hadassah Medical Center.
Partially misidentified. The stock formerly distributed by ATCC and CCRID was misidentified and was actually DU145 (CVCL_0105). This is not the case of the original stock from Hadassah Medical Center.
Partially misidentified. The stock formerly distributed by ATCC and CCRID was misidentified and was actually DU145 (CVCL_0105). This is not the case of the original stock from Hadassah Medical Center.
Partially misidentified. The stock formerly distributed by ATCC and CCRID was misidentified and was actually DU145 (CVCL_0105). This is not the case of the original stock from Hadassah Medical Center.
Partially misidentified. The stock formerly distributed by ATCC and CCRID was misidentified and was actually DU145 (CVCL_0105). This is not the case of the original stock from Hadassah Medical Center.
Contaminated. Shown to be a SU-DHL-8 derivative (ICLAC). Originally thought to originate from a 64 year old female patient with a diffuse large B-cell lymphoma.
Contaminated. Shown to be a SU-DHL-8 derivative (ICLAC). Originally thought to originate from a 64 year old female patient with a diffuse large B-cell lymphoma.
Contaminated. Shown to be a SU-DHL-8 derivative (ICLAC). Originally thought to originate from a 64 year old female patient with a diffuse large B-cell lymphoma.
Contaminated. Shown to be a SU-DHL-8 derivative (ICLAC). Originally thought to originate from a 64 year old female patient with a diffuse large B-cell lymphoma.
Contaminated. Shown to be a SU-DHL-8 derivative (ICLAC). Originally thought to originate from a 64 year old female patient with a diffuse large B-cell lymphoma.
Contaminated. Shown to be a SU-DHL-8 derivative (ICLAC). Originally thought to originate from a 64 year old female patient with a diffuse large B-cell lymphoma.
Contaminated. Shown to be a SU-DHL-8 derivative (ICLAC). Originally thought to originate from a 64 year old female patient with a diffuse large B-cell lymphoma.
Contaminated. Shown to be a SU-DHL-8 derivative (ICLAC). Originally thought to originate from a 47 year old female patient with a diffuse large B-cell lymphoma.
Contaminated. Shown to be a SU-DHL-8 derivative (ICLAC). Originally thought to originate from a 47 year old female patient with a diffuse large B-cell lymphoma.
Contaminated. Shown to be a SU-DHL-8 derivative (ICLAC). Originally thought to originate from a 47 year old female patient with a diffuse large B-cell lymphoma.
Contaminated. Shown to be a SU-DHL-8 derivative (ICLAC). Originally thought to originate from a 47 year old female patient with a diffuse large B-cell lymphoma.
Contaminated. Shown to be a SU-DHL-8 derivative (ICLAC). Originally thought to originate from a 47 year old female patient with a diffuse large B-cell lymphoma.
Contaminated. Shown to be a SU-DHL-8 derivative (ICLAC). Originally thought to originate from a 47 year old female patient with a diffuse large B-cell lymphoma.
Contaminated. Shown to be a SU-DHL-8 derivative (ICLAC). Originally thought to originate from a 47 year old female patient with a diffuse large B-cell lymphoma.
Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709; PubMed=20143388).
Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709; PubMed=20143388).
Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709; PubMed=20143388).
Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709; PubMed=20143388).
Contaminated. Shown to be a HCT 116 derivative (PubMed=10789716). Originally thought to originate from a male patient esophageal squamous cell carcinoma.
Contaminated. Shown to be a HCT 116 derivative (PubMed=10789716). Originally thought to originate from a male patient esophageal squamous cell carcinoma.
Contaminated. Shown to be a HCT 116 derivative (PubMed=10789716). Originally thought to originate from a male patient esophageal squamous cell carcinoma.
Contaminated. Shown to be a HCT 116 derivative (PubMed=10789716). Originally thought to originate from a male patient esophageal squamous cell carcinoma.
Contaminated. Shown to be a HCT 116 derivative (PubMed=10789716). Originally thought to originate from a female patient esophageal squamous cell carcinoma.
Contaminated. Shown to be a HCT 116 derivative (PubMed=10789716). Originally thought to originate from a female patient esophageal squamous cell carcinoma.
Contaminated. Shown to be a HCT 116 derivative (PubMed=10789716). Originally thought to originate from a female patient esophageal squamous cell carcinoma.
Contaminated. Shown to be a HCT 116 derivative (PubMed=10789716). Originally thought to originate from a female patient esophageal squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=23500642). Was thought to originate from an urinary bladder papillary carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=23500642). Was thought to originate from an urinary bladder papillary carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=23500642). Was thought to originate from an urinary bladder papillary carcinoma.
Contaminated. Shown to be a PC-3 derivative (PubMed=20143388).
Contaminated. Shown to be a PC-3 derivative (PubMed=20143388).
Contaminated. Shown to be a PC-3 derivative (PubMed=20143388).
Contaminated. Shown to be a PC-3 derivative (PubMed=20143388).
Contaminated. Shown to be a PC-3 derivative (PubMed=14518029; PubMed=20143388).
Contaminated. Shown to be a PC-3 derivative (PubMed=14518029; PubMed=20143388).
Contaminated. Shown to be a PC-3 derivative (PubMed=14518029; PubMed=20143388).
Contaminated. Shown to be a PC-3 derivative (PubMed=14518029; PubMed=20143388).
Contaminated. Shown to be a PC-3 derivative (PubMed=14518029; PubMed=20143388).
Contaminated. Shown to be a PC-3 derivative (PubMed=14518029; PubMed=20143388).
Contaminated. Shown to be a PC-3 derivative (PubMed=14518029; PubMed=20143388).
Contaminated. Shown to be a PC-3 derivative (PubMed=20143388).
Contaminated. Shown to be a PC-3 derivative (PubMed=20143388).
Contaminated. Shown to be a PC-3 derivative (PubMed=20143388).
Contaminated. Shown to be a PC-3 derivative (PubMed=20143388).
Contaminated. Shown to be a PC-3 derivative (PubMed=14518029; PubMed=20143388).
Contaminated. Shown to be a PC-3 derivative (PubMed=14518029; PubMed=20143388).
Contaminated. Shown to be a PC-3 derivative (PubMed=14518029; PubMed=20143388).
Possibly misidentified. Was reported to originate from the same patient as E006AA (CVCL_4834) which has been shown to be a 786-O derivative (CVCL_1051). But as this cell line is non-tumorigenic it could well originate from the prostate carcinoma patient.
Authors of PubMed=26934856 have only been able to detect 3 out of 16 STR loci. Either there was a problem with the STR detection or this cell line is contaminated by non-human DNA (CelloPub=CLPUB00451).
Contaminated. Shown to be a PC-3 derivative (PubMed=20143388). Originally thought to originate from a 67 year old male patient with prostate carcinoma.
Contaminated. Shown to be a PC-3 derivative (PubMed=20143388). Originally thought to originate from a 67 year old male patient with prostate carcinoma.
Contaminated. Shown to be a PC-3 derivative (PubMed=20143388). Originally thought to originate from a 67 year old male patient with prostate carcinoma.
Contaminated. Shown to be a DU145 derivative (PubMed=20143388). Originally thought to originate from a patient of unknown age with a primary prostate adenocarcinoma.
Contaminated. Shown to be a DU145 derivative (PubMed=20143388). Originally thought to originate from a patient of unknown age with a primary prostate adenocarcinoma.
Contaminated. Shown to be a 786-O derivative (PubMed=31416301). Originally thought to originate from a 50 year old patient with a prostate carcinoma.
Contaminated. Shown to be a 786-O derivative (PubMed=31416301). Originally thought to originate from a 50 year old patient with a prostate carcinoma.
Contaminated. Shown to be a 786-O derivative (PubMed=31416301). Originally thought to originate from a 50 year old patient with a prostate carcinoma.
Contaminated. Shown to be a FU-RPNT-1 derivative (PubMed=20143388).
Contaminated. Shown to be a FU-RPNT-1 derivative (PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=14518029; PubMed=20143388). Originally thought to originate from a moderately differentiated primary adenocarcinoma of the prostate.
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764). Was originally thought to originate from a gingivo-labial moderately differentiated squamous carcinoma.
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764). Was originally thought to originate from a gingivo-labial moderately differentiated squamous carcinoma.
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764). Was originally thought to originate from a gingivo-labial moderately differentiated squamous carcinoma.
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
Contaminated. Shown to be a UM-SCC-1 derivative (PubMed=21868764).
Contaminated. Shown to be a UM-SCC-1 derivative (PubMed=21868764).
Contaminated. Shown to be a UM-SCC-1 derivative (PubMed=21868764).
Contaminated. Shown to be a UM-SCC-1 derivative (PubMed=21868764).
Contaminated. Shown to be a UM-SCC-1 derivative (PubMed=21868764).
Contaminated. Shown to be a UM-SCC-1 derivative (PubMed=21868764).
Contaminated. Shown to be a UM-SCC-1 derivative (PubMed=21868764).
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
Contaminated. Shown to be a PA-1 derivative (PubMed=22710073).
Contaminated. Shown to be a OAW28 derivative (PubMed=20143388).
Contaminated. Shown to be a OAW28 derivative (PubMed=20143388).
Contaminated. Shown to be a OAW28 derivative (PubMed=20143388).
Contaminated. Shown to be a OAW28 derivative (PubMed=20143388).
Contaminated. Shown to be a OAW28 derivative (PubMed=20143388).
As this cell line is reported in a patent originating from authors who have retracted their papers based on the same type of techniques, this cell line origin is doubtful.
Probably contaminated. The STR profile is identical to that of the RD-ES cell line. Originally thought to originate from a giant cell tumor excised in 1986 from tumor tissue of a 33 year old female patient.
Probably contaminated. The STR profile is identical to that of the RD-ES cell line. Originally thought to originate from a giant cell tumor excised in 1986 from tumor tissue of a 33 year old female patient.
Probably contaminated. The STR profile is identical to that of the RD-ES cell line. Originally thought to originate from a giant cell tumor excised in 1986 from tumor tissue of a 42 year old female patient.
Probably contaminated. The STR profile is identical to that of the RD-ES cell line. Originally thought to originate from a giant cell tumor excised in 1986 from tumor tissue of a 42 year old female patient.
Probably contaminated. Shown not to be originating from the normal human esophageal cell HE-451 as previously thought (PubMed=1703038).
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Contaminated. Parent cell line (SKW-3) has been shown to be a KE-37 derivative.
Contaminated. Parent cell line (BHP 2-7) has been shown to be a TPC-1 derivative.
Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
Contaminated. Parent cell line (WRL-68) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Grand-parent cell line (KP-1N) has been shown to be a PANC-1 derivative.
Contaminated. Grand-parent cell line (KP-1N) has been shown to be a PANC-1 derivative.
Partially contaminated. The stock formerly distributed by Coriell (WC00058) contains a significant amount of mouse DNA (DOI=10.4172/1948-5956.1000196). This is not the case of the original Wistar stock which is now distributed by Rockland (DOI=10.4172/1948-5956.1000401).
Partially contaminated. The stock formerly distributed by Coriell (WC00058) contains a significant amount of mouse DNA (DOI=10.4172/1948-5956.1000196). This is not the case of the original Wistar stock which is now distributed by Rockland (DOI=10.4172/1948-5956.1000401).
Partially contaminated. The stock formerly distributed by Coriell (WC00058) contains a significant amount of mouse DNA (DOI=10.4172/1948-5956.1000196). This is not the case of the original Wistar stock which is now distributed by Rockland (DOI=10.4172/1948-5956.1000401).
Partially contaminated. The stock formerly distributed by Coriell (WC00058) contains a significant amount of mouse DNA (DOI=10.4172/1948-5956.1000196). This is not the case of the original Wistar stock which is now distributed by Rockland (DOI=10.4172/1948-5956.1000401).
Partially contaminated. The stock formerly distributed by Coriell (WC00058) contains a significant amount of mouse DNA (DOI=10.4172/1948-5956.1000196). This is not the case of the original Wistar stock which is now distributed by Rockland (DOI=10.4172/1948-5956.1000401).
Partially contaminated. The stock formerly distributed by Coriell (WC00058) contains a significant amount of mouse DNA (DOI=10.4172/1948-5956.1000196). This is not the case of the original Wistar stock which is now distributed by Rockland (DOI=10.4172/1948-5956.1000401).
Partially contaminated. The stock formerly distributed by Coriell (WC00058) contains a significant amount of mouse DNA (DOI=10.4172/1948-5956.1000196). This is not the case of the original Wistar stock which is now distributed by Rockland (DOI=10.4172/1948-5956.1000401).
Partially contaminated. The stock formerly distributed by Coriell (WC00058) contains a significant amount of mouse DNA (DOI=10.4172/1948-5956.1000196). This is not the case of the original Wistar stock which is now distributed by Rockland (DOI=10.4172/1948-5956.1000401).
Partially contaminated. The stock formerly distributed by Coriell (WC00058) contains a significant amount of mouse DNA (DOI=10.4172/1948-5956.1000196). This is not the case of the original Wistar stock which is now distributed by Rockland (DOI=10.4172/1948-5956.1000401).
Partially contaminated. The stock formerly distributed by Coriell (WC00058) contains a significant amount of mouse DNA (DOI=10.4172/1948-5956.1000196). This is not the case of the original Wistar stock which is now distributed by Rockland (DOI=10.4172/1948-5956.1000401).
Misidentified. Originally though to be a Hodgkin lymphoma cell line, but its real origin is not clear (PubMed=12592342; PubMed=20143388; PubMed=29533902).
Contaminated. Shown to be a KG-1 derivative (PubMed=16643607; PubMed=20143388).
Contaminated. Shown to be a KYO-1 derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from the peripheral blood of a 39 year old male patient with chronic myelogenous leukemia, BCR-ABL1 positive.
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a breast carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a breast carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a breast carcinoma.
Contaminated. Parent cell line (Matu) has been shown to be a HeLa derivative.
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a breast carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a breast carcinoma.
Possibly contaminated. May be a derivative of HeLa and another cell of unknown origin. The STR profile is highly similar to that of HeLa yet shows some specific differences that suggest a possible hybrid cell line.
Possibly contaminated. May be a derivative of HeLa and another cell of unknown origin. The STR profile is highly similar to that of HeLa yet shows some specific differences that suggest a possible hybrid cell line.
Possibly contaminated. May be a derivative of HeLa and another cell of unknown origin. The STR profile is highly similar to that of HeLa yet shows some specific differences that suggest a possible hybrid cell line.
Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a 53 year old male patient hepatocellular carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a 53 year old male patient hepatocellular carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a 53 year old male patient hepatocellular carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a 53 year old male patient hepatocellular carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a 53 year old male patient hepatocellular carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a 53 year old male patient hepatocellular carcinoma.
Contaminated. Parent cell line (BEL-7402) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (BEL-7402) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (BEL-7402) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (BEL-7402) has been shown to be a HeLa derivative.
Partially misidentified. For a period of time Asterand (now BioIVT) mistakenly distributed SUM149PT (CVCL_3422) under the designation of SUM229PE. This leads to the publication of a STR profile (PubMed=25877200) which was almost identical to that of SUM149PT.
Partially misidentified. For a period of time Asterand (now BioIVT) mistakenly distributed SUM149PT (CVCL_3422) under the designation of SUM229PE. This leads to the publication of a STR profile (PubMed=25877200) which was almost identical to that of SUM149PT.
Partially misidentified. For a period of time Asterand (now BioIVT) mistakenly distributed SUM149PT (CVCL_3422) under the designation of SUM229PE. This leads to the publication of a STR profile (PubMed=25877200) which was almost identical to that of SUM149PT.
Partially misidentified. For a period of time Asterand (now BioIVT) mistakenly distributed SUM149PT (CVCL_3422) under the designation of SUM229PE. This leads to the publication of a STR profile (PubMed=25877200) which was almost identical to that of SUM149PT.
Partially misidentified. For a period of time Asterand (now BioIVT) mistakenly distributed SUM149PT (CVCL_3422) under the designation of SUM229PE. This leads to the publication of a STR profile (PubMed=25877200) which was almost identical to that of SUM149PT.
Partially misidentified. For a period of time Asterand (now BioIVT) mistakenly distributed SUM149PT (CVCL_3422) under the designation of SUM229PE. This leads to the publication of a STR profile (PubMed=25877200) which was almost identical to that of SUM149PT.
Partially misidentified. For a period of time Asterand (now BioIVT) mistakenly distributed SUM149PT (CVCL_3422) under the designation of SUM229PE. This leads to the publication of a STR profile (PubMed=25877200) which was almost identical to that of SUM149PT.
Contaminated. Shown to be a A-172 derivative (ICLAC, from personal communication of Bigner D.D.). Originally thought to originate from a glioblastoma from a female patient.
Contaminated. Shown to be a A-172 derivative (ICLAC, from personal communication of Bigner D.D.). Originally thought to originate from a glioblastoma from a female patient.
Contaminated. Shown to be a A-172 derivative (ICLAC, from personal communication of Bigner D.D.). Originally thought to originate from a glioblastoma from a female patient.
Contaminated. Shown to be a A-172 derivative (ICLAC, from personal communication of Bigner D.D.). Originally thought to originate from a glioblastoma from a female patient.
Contaminated. Shown to be a A-172 derivative (ICLAC, from personal communication of Bigner D.D.). Originally thought to originate from a glioblastoma from a female patient.
Contaminated. KTCTL-2 and KTCTL-30 have been shown to be identical (CLS; on the basis of STR profile).
Contaminated. KTCTL-2 and KTCTL-30 have been shown to be identical (CLS; on the basis of STR profile).
Contaminated. KTCTL-2 and KTCTL-30 have been shown to be identical (CLS; on the basis of STR profile).
Contaminated. KTCTL-2 and KTCTL-30 have been shown to be identical (CLS; on the basis of STR profile).
Contaminated. KTCTL-2 and KTCTL-30 have been shown to be identical (CLS; on the basis of STR profile).
Contaminated. KTCTL-2 and KTCTL-30 have been shown to be identical (CLS; on the basis of STR profile).
Contaminated. KTCTL-2 and KTCTL-30 have been shown to be identical (CLS; on the basis of STR profile).
Contaminated. KTCTL-2 and KTCTL-30 have been shown to be identical (CLS; on the basis of STR profile).
Misidentified. Originally thought to be a Wilms tumor cell line but is a kidney rhabdoid tumor cell line (DOI=10.1002/cnr2.1110).
Misidentified. Originally thought to be a Wilms tumor cell line but is a kidney rhabdoid tumor cell line (DOI=10.1002/cnr2.1110).
Contaminated. Shown to be a Flow1000 derivative.
Contaminated. Shown to be a Flow1000 derivative.
Contaminated. Shown to be a Flow1000 derivative.
Contaminated. Shown to be a JHU-022 derivative (PubMed=21868764). Originally thought to originate from the lymph node of a metastatic floor of mouth carcinoma in a 62 year old female patient.
Contaminated. Shown to be a JHU-022 derivative (PubMed=21868764). Originally thought to originate from the lymph node of a metastatic floor of mouth carcinoma in a 62 year old female patient.
Contaminated. Shown to be a JHU-022 derivative (PubMed=21868764). Originally thought to originate from the lymph node of a metastatic floor of mouth carcinoma in a 62 year old female patient.
Contaminated. Shown to be a JHU-022 derivative (PubMed=21868764). Originally thought to originate from the lymph node of a metastatic floor of mouth carcinoma in a 62 year old female patient.
Contaminated. Shown to be a JHU-022 derivative (PubMed=21868764). Originally thought to originate from the lymph node of a metastatic floor of mouth carcinoma in a 62 year old female patient.
Contaminated. Shown to be a JHU-022 derivative (PubMed=21868764). Originally thought to originate from the lymph node of a metastatic floor of mouth carcinoma in a 62 year old female patient.
Contaminated. Shown to be a JHU-022 derivative (PubMed=21868764). Originally thought to originate from the lymph node of a metastatic floor of mouth carcinoma in a 62 year old female patient.
Contaminated. Shown to be a JHU-022 derivative (PubMed=21868764). Originally thought to originate from the lymph node of a metastatic floor of mouth carcinoma in a 62 year old female patient.
Contaminated. Shown to be a FaDu derivative (PubMed=21868764).
Contaminated. Shown to be a FaDu derivative (PubMed=21868764).
Contaminated. Shown to be a FaDu derivative (PubMed=21868764).
Contaminated. Shown to be a FaDu derivative (PubMed=21868764).
Contaminated. Shown to be a FaDu derivative (PubMed=21868764).
Contaminated. Shown to be a FaDu derivative (PubMed=21868764).
Contaminated. Shown to be a PC-3 derivative (PubMed=21868764). Originally thought to originate from a 58 year old female patient oropharyngeal squamous cell carcinoma.
Contaminated. Shown to be a PC-3 derivative (PubMed=21868764). Originally thought to originate from a 58 year old female patient oropharyngeal squamous cell carcinoma.
Contaminated. Shown to be a PC-3 derivative (PubMed=21868764). Originally thought to originate from a 58 year old female patient oropharyngeal squamous cell carcinoma.
Contaminated. Shown to be a PC-3 derivative (PubMed=21868764). Originally thought to originate from a 58 year old female patient oropharyngeal squamous cell carcinoma.
Contaminated. Shown to be a PC-3 derivative (PubMed=21868764). Originally thought to originate from a 58 year old female patient oropharyngeal squamous cell carcinoma.
Contaminated. Shown to be a PC-3 derivative (PubMed=21868764). Originally thought to originate from a 58 year old female patient oropharyngeal squamous cell carcinoma.
Contaminated. Shown to be a PC-3 derivative (PubMed=21868764). Originally thought to originate from a 58 year old female patient oropharyngeal squamous cell carcinoma.
Contaminated. Shown to be a A-549 derivative (PubMed=21868764). Originally thought to originate from a base of tongue squamous cell carcinoma.
Contaminated. Shown to be a A-549 derivative (PubMed=21868764). Originally thought to originate from a base of tongue squamous cell carcinoma.
Contaminated. Shown to be a A-549 derivative (PubMed=21868764). Originally thought to originate from a base of tongue squamous cell carcinoma.
Contaminated. Shown to be a A-549 derivative (PubMed=21868764). Originally thought to originate from a base of tongue squamous cell carcinoma.
Contaminated. Shown to be a A-549 derivative (PubMed=21868764). Originally thought to originate from a base of tongue squamous cell carcinoma.
Contaminated. Shown to be a A-549 derivative (PubMed=21868764). Originally thought to originate from a base of tongue squamous cell carcinoma.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
Misidentified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be a B-lymphoblastoid cell line (PubMed=29533902).
Contaminated. Parent cell line (L-132) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (L-132) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Contaminated. Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Shown to be a TPC-1 derivative (PubMed=18713817; PubMed=20143388).
Contaminated. Shown to be a TPC-1 derivative (PubMed=18713817; PubMed=20143388).
Contaminated. Shown to be a TPC-1 derivative (PubMed=18713817; PubMed=20143388).
Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a M14 derivative (PubMed=28940260). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a M14 derivative (PubMed=28940260). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a M14 derivative (PubMed=28940260). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a TPC-1 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764).
Contaminated. Shown to be a TPC-1 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764).
Contaminated. Shown to be a TPC-1 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764).
Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a TPC-1 derivative (PubMed=18713817; PubMed=20143388).
Contaminated. Shown to be a TPC-1 derivative (PubMed=18713817; PubMed=20143388).
Contaminated. Shown to be a TPC-1 derivative (PubMed=18713817; PubMed=20143388).
Contaminated. Shown to be a A-375 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
Contaminated. Shown to be a A-375 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
Contaminated. Shown to be a A-375 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
Contaminated. Shown to be a A-375 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
Contaminated. Shown to be a A-375 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
Contaminated. Shown to be a A-375 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
Contaminated. Shown to be a A-375 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388). Originally thought to originate from a thyroid gland follicular carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388). Originally thought to originate from a thyroid gland follicular carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388). Originally thought to originate from a thyroid gland follicular carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388). Originally thought to originate from a thyroid gland papillary carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388).
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388).
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388).
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388).
Contaminated. Shown to be a GLAG-66 derivative (PubMed=20143388).
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388).
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388).
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388).
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388).
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388).
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388).
Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388).
Contaminated. From its STR profile it seems to be a U-937 derivative.
Contaminated. From its STR profile it seems to be a U-937 derivative.
Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a 69 year old male patient hepatocellular carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a 69 year old male patient hepatocellular carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a 69 year old male patient hepatocellular carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a 69 year old male patient hepatocellular carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a 69 year old male patient hepatocellular carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a 69 year old male patient hepatocellular carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a 69 year old male patient hepatocellular carcinoma.
Partially contaminated. Some stocks are contaminated by MCF-7 (PubMed=22710073; PubMed=25321415).
Partially contaminated. Some stocks are contaminated by MCF-7 (PubMed=22710073; PubMed=25321415).
Partially contaminated. Some stocks are contaminated by MCF-7 (PubMed=22710073; PubMed=25321415).
Partially contaminated. Some stocks are contaminated by MCF-7 (PubMed=22710073; PubMed=25321415).
Partially contaminated. Some stocks are contaminated by MCF-7 (PubMed=22710073; PubMed=25321415).
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a 35 year old female patient with hepatocellular carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a 35 year old female patient with hepatocellular carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a 35 year old female patient with hepatocellular carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706; PubMed=28851942). Originally thought to originate from a female patient with a tongue squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706; PubMed=28851942). Originally thought to originate from a female patient with a tongue squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706; PubMed=28851942). Originally thought to originate from a female patient with a tongue squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a hepatocellular carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a hepatocellular carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a hepatocellular carcinoma.
Contaminated. Shown to be a OVCAR-2 derivative (PubMed=22710073).
Contaminated. Shown to be a OVCAR-2 derivative (PubMed=22710073).
Contaminated. Shown to be a OVCAR-2 derivative (PubMed=22710073).
Contaminated. Shown to be a OVCAR-2 derivative (PubMed=22710073).
Contaminated. Shown to be a Lu-134-A (or Lu-134-B) derivative (PubMed=16643607; PubMed=20143388). Originally thought to originate from a 61 year old male patient with small cell lung carcinoma.
Contaminated. Shown to be a Lu-134-A (or Lu-134-B) derivative (PubMed=16643607; PubMed=20143388). Originally thought to originate from a 61 year old male patient with small cell lung carcinoma.
Contaminated. Shown to be a Lu-134-A (or Lu-134-B) derivative (PubMed=16643607; PubMed=20143388). Originally thought to originate from a 61 year old male patient with small cell lung carcinoma.
Contaminated. Shown to be a Lu-134-A (or Lu-134-B) derivative (PubMed=16643607; PubMed=20143388). Originally thought to originate from a 61 year old male patient with small cell lung carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706; CCRID). Originally thought to originate from the ascites of a 51 year old female patient with ovarian serous cystadenocarcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706; CCRID). Originally thought to originate from the ascites of a 51 year old female patient with ovarian serous cystadenocarcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706; CCRID). Originally thought to originate from the ascites of a 51 year old female patient with ovarian serous cystadenocarcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706; CCRID). Originally thought to originate from the ascites of a 51 year old female patient with ovarian serous cystadenocarcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=19557180; PubMed=20143388; PubMed=21868764; PubMed=26116706). Originally thought to originate from a 28 year old female patient with salivary gland adenoid cystic carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=19557180; PubMed=20143388; PubMed=21868764; PubMed=26116706). Originally thought to originate from a 28 year old female patient with salivary gland adenoid cystic carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=19557180; PubMed=20143388; PubMed=21868764; PubMed=26116706). Originally thought to originate from a 28 year old female patient with salivary gland adenoid cystic carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=19557180; PubMed=20143388; PubMed=21868764). Originally thought to originate from a 49 year old male patient with salivary gland adenoid cystic carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=19557180; PubMed=20143388; PubMed=21868764). Originally thought to originate from a 49 year old male patient with salivary gland adenoid cystic carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=19557180; PubMed=20143388; PubMed=21868764). Originally thought to originate from a 49 year old male patient with salivary gland adenoid cystic carcinoma.
Contaminated. Parent cell line (ACC-2) has been shown to be a HeLa derivative (PubMed=19557180; PubMed=20143388; PubMed=21868764; PubMed=26116706).
Contaminated. Parent cell line (ACC-2) has been shown to be a HeLa derivative (PubMed=19557180; PubMed=20143388; PubMed=21868764; PubMed=26116706).
Contaminated. Parent cell line (ACC-2) has been shown to be a HeLa derivative (PubMed=19557180; PubMed=20143388; PubMed=21868764; PubMed=26116706).
Contaminated. Shown to be a T24 derivative (PubMed=19557180; PubMed=20143388). Originally thought to originate from a 56 year old female patient with salivary gland adenoid cystic carcinoma.
Contaminated. Shown to be a T24 derivative (PubMed=19557180; PubMed=20143388). Originally thought to originate from a 56 year old female patient with salivary gland adenoid cystic carcinoma.
Contaminated. On the basis of the STR profile (PubMed=18196576) it is identical to CNE-2 and seems to be a hybrid of Hela and of cell line of unknow origin. This is also confirmed by RNASeq data from PubMed=24991015. Originally thought to originate from a 58 year old female patient with a nasopharyngeal carcinoma.
Contaminated. On the basis of the STR profile (PubMed=18196576) it is identical to CNE-2 and seems to be a hybrid of Hela and of cell line of unknow origin. This is also confirmed by RNASeq data from PubMed=24991015. Originally thought to originate from a 58 year old female patient with a nasopharyngeal carcinoma.
Contaminated. On the basis of the STR profile (PubMed=18196576) it is identical to CNE-2 and seems to be a hybrid of Hela and of cell line of unknow origin. This is also confirmed by RNASeq data from PubMed=24991015. Originally thought to originate from a 58 year old female patient with a nasopharyngeal carcinoma.
Contaminated. On the basis of the STR profile (PubMed=18196576) it is identical to CNE-1 and seems to be a hybrid of Hela and of cell line of unknow origin. Originally thought to originate from a nasopharyngeal carcinoma from a male patient.
Contaminated. On the basis of the STR profile (PubMed=18196576) it is identical to CNE-1 and seems to be a hybrid of Hela and of cell line of unknow origin. Originally thought to originate from a nasopharyngeal carcinoma from a male patient.
Probably contaminated. Parent cell line (CNE-2) has been shown to be a hybrid of Hela and of cell line of unknow origin.
Probably contaminated. Parent cell line (CNE-2) has been shown to be a hybrid of Hela and of cell line of unknow origin.
Probably contaminated. Parent cell line (CNE-2) has been shown to be a hybrid of Hela and of cell line of unknow origin.
Contaminated. Parent cell line (GLC-82) has been shown to be a HeLa derivative.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a normal fetal liver.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a normal fetal liver.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a normal fetal liver.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a normal fetal liver.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a normal fetal liver.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a normal fetal liver.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a normal fetal liver.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a 46 year old female patient lung adenocarcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a 46 year old female patient lung adenocarcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a 46 year old female patient lung adenocarcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a 46 year old female patient lung adenocarcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a 46 year old female patient lung adenocarcinoma.
Contaminated. Shown to be a M14 derivative (PubMed=28940260). Originally thought to originate from a female patient with uveal melanoma.
Contaminated. Shown to be a M14 derivative (PubMed=28940260). Originally thought to originate from a female patient with uveal melanoma.
Contaminated. Shown to be a M14 derivative (PubMed=28940260). Originally thought to originate from a female patient with uveal melanoma.
Contaminated. Shown to be a M14 derivative (PubMed=28940260). Originally thought to originate from a female patient with uveal melanoma.
Contaminated. Parent cell line (OCM-1) has been shown to be a M14 derivative.
Contaminated. Parent cell line (OCM-1) has been shown to be a M14 derivative.
Contaminated. Parent cell line (OCM-1) has been shown to be a M14 derivative.
Contaminated. Shown to be a SK-MEL-28 derivative (PubMed=22236444 and STR profile from PubMed=18689700). Originally thought to originate from an uveal melanoma.
Contaminated. Shown to be a SK-MEL-28 derivative (PubMed=22236444 and STR profile from PubMed=18689700). Originally thought to originate from an uveal melanoma.
Contaminated. Shown to be a SK-MEL-28 derivative (PubMed=22236444 and STR profile from PubMed=18689700). Originally thought to originate from an uveal melanoma.
Contaminated. Shown to be a SK-MEL-28 derivative (PubMed=22236444 and STR profile from PubMed=18689700). Originally thought to originate from an uveal melanoma.
Contaminated. Shown to be a SK-MEL-28 derivative (PubMed=22236444 and STR profile from PubMed=18689700). Originally thought to originate from an uveal melanoma.
Contaminated. Shown to be a SK-MEL-28 derivative (PubMed=22236444 and STR profile from PubMed=18689700). Originally thought to originate from an uveal melanoma.
Contaminated. Shown to be a SK-MEL-28 derivative (PubMed=22236444 and STR profile from PubMed=18689700). Originally thought to originate from an uveal melanoma.
Contaminated. Shown to be a SK-MEL-28 derivative (PubMed=22236444 and STR profile from PubMed=18689700). Originally thought to originate from an uveal melanoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706; PubMed=28807831). Originally thought to originate from an immortalized but non-transformed hepatocytes from a 35 year old female.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706; PubMed=28807831). Originally thought to originate from an immortalized but non-transformed hepatocytes from a 35 year old female.
Contaminated. Shown to be a ME-180 derivative (PubMed=22570425).
Contaminated. Shown to be a ME-180 derivative (PubMed=22570425).
Contaminated. Shown to be a ME-180 derivative (PubMed=22570425).
Contaminated. Shown to be a HeLa derivative (CCRID; PubMed=26116706). Originally thought to be a lung adenocarcinoma.
Contaminated. Shown to be a HeLa derivative (CCRID; PubMed=26116706). Originally thought to be a lung adenocarcinoma.
Contaminated. Shown to be a HeLa derivative (CCRID; PubMed=26116706). Originally thought to be a lung adenocarcinoma.
Contaminated. Shown to be a HeLa derivative (CCRID; PubMed=26116706). Originally thought to be a lung adenocarcinoma.
Partially contaminated. Some stocks are contaminated by UM-SCC-1 (PubMed=21868764).
Partially contaminated. Some stocks are contaminated by UM-SCC-1 (PubMed=21868764).
Partially contaminated. Some stocks are contaminated by UM-SCC-1 (PubMed=21868764).
Partially contaminated. Some stocks are contaminated by UM-SCC-1 (PubMed=21868764).
Partially contaminated. Some stocks are contaminated by UM-SCC-1 (PubMed=21868764).
Partially contaminated. Some stocks are contaminated by UM-SCC-1 (PubMed=21868764).
Partially contaminated. Some stocks are contaminated by UM-SCC-1 (PubMed=21868764).
Partially contaminated. Some stocks are contaminated by UM-SCC-1 (PubMed=21868764).
Partially contaminated. Some stocks are contaminated by UM-SCC-1 (PubMed=21868764).
Partially contaminated. Some stocks are contaminated by T404/T406/Tu 1387Tu 158LN/Tu 159/Tu 182/Tu 212/Tu 212LN (PubMed=21868764).
Partially contaminated. Some stocks are contaminated by T404/T406/Tu 1387Tu 158LN/Tu 159/Tu 182/Tu 212/Tu 212LN (PubMed=21868764).
Partially contaminated. Some stocks are contaminated by T404/T406/Tu 1387Tu 158LN/Tu 159/Tu 182/Tu 212/Tu 212LN (PubMed=21868764).
Partially contaminated. Some stocks are contaminated by T404/T406/Tu 1387Tu 158LN/Tu 159/Tu 182/Tu 212/Tu 212LN (PubMed=21868764).
Partially contaminated. Some stocks are contaminated by T404/T406/Tu 1387Tu 158LN/Tu 159/Tu 182/Tu 212/Tu 212LN (PubMed=21868764).
Partially contaminated. Some stocks are contaminated by T404/T406/Tu 1387Tu 158LN/Tu 159/Tu 182/Tu 212/Tu 212LN (PubMed=21868764).
Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Partially contaminated. Some stocks were contaminated by HU-3 (PubMed=10516762).
Partially contaminated. Some stocks were contaminated by HU-3 (PubMed=10516762).
Partially contaminated. Some stocks were contaminated by HU-3 (PubMed=10516762).
Contaminated. Shown to be a AsPC-1 derivative (PubMed=20143388).
Contaminated. Shown to be a AsPC-1 derivative (PubMed=20143388).
Contaminated. Shown to be a AsPC-1 derivative (PubMed=20143388).
Contaminated. Shown to be a AsPC-1 derivative (PubMed=20143388).
Contaminated. Shown to be a AsPC-1 derivative (PubMed=20143388).
Partially contaminated. Some stocks where shown to be a IMR-32 derivative.
Partially contaminated. Some stocks where shown to be a IMR-32 derivative.
Partially contaminated. Some stocks where shown to be a IMR-32 derivative.
Contaminated. Shown to be a JEG-3 derivative (PubMed=20143388).
Contaminated. Parent cell line (J-96) has been shown to be a HeLa derivative (PubMed=20143388).
Probably misidentified. Originally thought to be a Hodgkin lymphoma cell line, but its real origin is not clear (PubMed=29533902).
Contaminated. Shown to be a HT-29 derivative. Originally thought to originate from a lung carcinoma.
Contaminated. Shown to be a HT-29 derivative. Originally thought to originate from a lung carcinoma.
Contaminated. Shown to be a HT-29 derivative. Originally thought to originate from a lung carcinoma.
Contaminated. Shown to be a HT-29 derivative. Originally thought to originate from a lung carcinoma.
Contaminated. Shown to be a HT-29 derivative. Originally thought to originate from a lung carcinoma.
Contaminated. Shown to be a Ishikawa 3-H-12 derivative (PubMed=22710073).
Contaminated. Shown to be a Ishikawa 3-H-12 derivative (PubMed=22710073).
Contaminated. Shown to be a Ishikawa 3-H-12 derivative (PubMed=22710073).
Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388). Originally thought to originate from the skin and muscle explant of an embryo.
Misidentified. Grand-parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
Contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
Contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
Contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
Contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
Contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
Contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
Contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
Contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
Contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
Contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
Contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
Contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
Contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
Contaminated. Shown to be a HeLa derivative (PubMed=6244232; PubMed=20143388). Originally thought to originate from a prostate carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=6244232; PubMed=20143388). Originally thought to originate from a prostate carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=6244232; PubMed=20143388). Originally thought to originate from a prostate carcinoma.
Partially contaminated. At least one lab used a stock contaminated by T24 (CVCL_0554) (PubMed=29873307).
Partially contaminated. At least one lab used a stock contaminated by T24 (CVCL_0554) (PubMed=29873307).
Partially contaminated. At least one lab used a stock contaminated by T24 (CVCL_0554) (PubMed=29873307).
Partially contaminated. At least one lab used a stock contaminated by T24 (CVCL_0554) (PubMed=29873307).
Partially contaminated. At least one lab used a stock contaminated by T24 (CVCL_0554) (PubMed=29873307).
Partially contaminated. At least one lab used a stock contaminated by T24 (CVCL_0554) (PubMed=29873307).
Partially contaminated. At least one lab used a stock contaminated by T24 (CVCL_0554) (PubMed=29873307).
Partially contaminated. At least one lab used a stock contaminated by T24 (CVCL_0554) (PubMed=29873307).
Partially contaminated. At least one lab used a stock contaminated by T24 (CVCL_0554) (PubMed=29873307).
Partially contaminated. At least one lab used a stock contaminated by T24 (CVCL_0554) (PubMed=29873307).
Partially contaminated. At least one lab used a stock contaminated by T24 (CVCL_0554) (PubMed=29873307).
Partially contaminated. At least one lab used a stock contaminated by T24 (CVCL_0554) (PubMed=29873307).
Contaminated. Parent cell line (Tca8113) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (Tca8113) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (Tca8113) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (Tca8113) has been shown to be a HeLa derivative.
Contaminated. Shown to be a HPB-ALL derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a 62 year old female patient with a T-cell lymphoid malignancy.
Contaminated. Shown to be a HPB-ALL derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a 62 year old female patient with a T-cell lymphoid malignancy.
Contaminated. Shown to be a HeLa derivative (PubMed=26780976; PubMed=26781072). Originally thought to originate from a maxillary sinus squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26780976; PubMed=26781072). Originally thought to originate from a maxillary sinus squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26780976; PubMed=26781072). Originally thought to originate from a lung metastasis of a tongue squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26780976; PubMed=26781072). Originally thought to originate from a lung metastasis of a tongue squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26780976; PubMed=26781072). Originally thought to originate from an hypopharyngeal squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26780976; PubMed=26781072). Originally thought to originate from an hypopharyngeal squamous cell carcinoma.
Contaminated. YCU-L891 and YCU-T891 have been shown to be identical (PubMed=26780976; PubMed=26781072).
Contaminated. YCU-L891 and YCU-T891 have been shown to be identical (PubMed=26780976; PubMed=26781072).
Contaminated. YCU-L891 and YCU-T891 have been shown to be identical (PubMed=26780976; PubMed=26781072).
Contaminated. YCU-L891 and YCU-T891 have been shown to be identical (PubMed=26780976; PubMed=26781072).
Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=20075370). Originally thought to originate from a esophageal adenocarcinoma.
Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=20075370). Originally thought to originate from a esophageal adenocarcinoma.
Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=20075370). Originally thought to originate from a esophageal adenocarcinoma.
Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=20075370). Originally thought to originate from a esophageal adenocarcinoma.
Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=20075370). Originally thought to originate from a esophageal adenocarcinoma.
Contaminated. Shown to be a NCI-H460 derivative (PubMed=20075370). Originally thought to originate from a esophageal adenocarcinoma.
Contaminated. Shown to be a NCI-H460 derivative (PubMed=20075370). Originally thought to originate from a esophageal adenocarcinoma.
Contaminated. Shown to be a NCI-H460 derivative (PubMed=20075370). Originally thought to originate from a esophageal adenocarcinoma.
Contaminated. Shown to be a NCI-H460 derivative (PubMed=20075370). Originally thought to originate from a esophageal adenocarcinoma.
Contaminated. Shown to be a SK-GT-2 derivative (PubMed=20075370). Originally thought to originate from a 67 year old male patient with esophageal adenocarcinoma.
Contaminated. Shown to be a SK-GT-2 derivative (PubMed=20075370). Originally thought to originate from a 67 year old male patient with esophageal adenocarcinoma.
Contaminated. Shown to be a U-937 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a U-937 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a CTV-1 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a CTV-1 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a CTV-1 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=19375735; PubMed=20143388). Originally thought to originate from a 61 year old male patient with a bladder transitional cell carcinoma.
Contaminated. Shown to be a T24 derivative (PubMed=19375735; PubMed=20143388). Originally thought to originate from a 61 year old male patient with a bladder transitional cell carcinoma.
Contaminated. Shown to be a T24 derivative (PubMed=19375735; PubMed=20143388). Originally thought to originate from a 61 year old male patient with a bladder transitional cell carcinoma.
Contaminated. Shown to be a T24 derivative (PubMed=19375735; PubMed=20143388). Originally thought to originate from a 61 year old male patient with a bladder transitional cell carcinoma.
Contaminated. Shown to be a T24 derivative (PubMed=19375735; PubMed=20143388). Originally thought to originate from a 61 year old male patient with a bladder transitional cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a DJM-1 derivative (PubMed=16643607; PubMed=20143388).
Contaminated. Shown to be a DJM-1 derivative (PubMed=16643607; PubMed=20143388).
Contaminated. Shown to be a DJM-1 derivative (PubMed=16643607; PubMed=20143388).
Contaminated. Shown to be a MMAc derivative (PubMed=16643607; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 67 year old male patient with lung adenocarcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=16643607; PubMed=20143388). Originally thought to originate from a 42 year old male patient with melanoma.
Contaminated. Shown to be a NALM-6 derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a NALM-6 derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a NALM-6 derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Parent cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Parent cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Parent cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Parent cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Parent cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Parent cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Parent cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Parent cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Parent cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Parent cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Parent cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 68 year old male patient with lung squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 68 year old male patient with lung squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 68 year old male patient with lung squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 68 year old male patient with lung squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 68 year old male patient with lung squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from the lymph node metastasis of a 48 year old male patient with lung squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from the lymph node metastasis of a 48 year old male patient with lung squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from the lymph node metastasis of a 48 year old male patient with lung squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from the lymph node metastasis of a 48 year old male patient with lung squamous cell carcinoma.
Contaminated. Shown to be a T24 derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from an astrocytoma.
Contaminated. Shown to be a T24 derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from an astrocytoma.
Contaminated. Shown to be a T24 derivative (PubMed=10508494; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=10508494; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=10508494; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=8105864; PubMed=20143388). Originally thought to be a derivative of HCV-29.
Contaminated. Shown to be a T24 derivative (PubMed=8105864; PubMed=20143388). Originally thought to be a derivative of HCV-29.
Contaminated. Parent cell line (HKMUS) has been shown to be a SKG-II-SF derivative (PubMed=16643607; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=16643607; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=16643607; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a vaginal melanoma.
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a vaginal melanoma.
Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=8105864; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=8105864; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=8105864; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=8105864; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=8105864; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=8105864; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=8105864; PubMed=20143388).
Contaminated. Shown to be a J82 derivative (PubMed=7905254; PubMed=20143388). Originally thought to originate from the histologically normal ureter of a patient with clear cell renal carcinoma.
Contaminated. Shown to be a J82 derivative (PubMed=7905254; PubMed=20143388). Originally thought to originate from the histologically normal ureter of a patient with clear cell renal carcinoma.
Contaminated. Shown to be a J82 derivative (PubMed=7905254; PubMed=20143388). Originally thought to originate from the histologically normal ureter of a patient with clear cell renal carcinoma.
Contaminated. Shown to be a J82 derivative (PubMed=7905254; PubMed=20143388). Originally thought to originate from the histologically normal ureter of a patient with clear cell renal carcinoma.
Contaminated. Parent cell line (Hu609) has been shown to be a J82 derivative.
Contaminated. Parent cell line (Hu609) has been shown to be a J82 derivative.
Contaminated. Parent cell line (Hu609) has been shown to be a J82 derivative.
Contaminated. Shown to be a T24 derivative (PubMed=8105864; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=8105864; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=8105864; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=8105864; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=8105864; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a maxillary carcinoma from a male patient (from which IMC-3 and IMC-4 were also supposed to be derived).
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a maxillary carcinoma from a male patient (from which IMC-3 and IMC-4 were also supposed to be derived).
Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to originate from a maxillary carcinoma from a male patient (from which IMC-2 and IMC-4 were also supposed to be derived).
Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to originate from a maxillary carcinoma from a male patient (from which IMC-2 and IMC-3 were also supposed to be derived).
Contaminated. Shown to be a NALM-6 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=66218; PubMed=93571; PubMed=1246601; PubMed=4469665; PubMed=6451928; PubMed=20143388). Originally thought to originate from a benign prostatic hyperplasia biopsy from Monroe Vincent one of the authors of the original paper.
Contaminated. Shown to be a HeLa derivative (PubMed=66218; PubMed=93571; PubMed=1246601; PubMed=4469665; PubMed=6451928; PubMed=20143388). Originally thought to originate from a benign prostatic hyperplasia biopsy from Monroe Vincent one of the authors of the original paper.
Contaminated. Shown to be a HeLa derivative (PubMed=66218; PubMed=93571; PubMed=1246601; PubMed=4469665; PubMed=6451928; PubMed=20143388). Originally thought to originate from a benign prostatic hyperplasia biopsy from Monroe Vincent one of the authors of the original paper.
Contaminated. Shown to be a HeLa derivative (PubMed=66218; PubMed=93571; PubMed=1246601; PubMed=4469665; PubMed=6451928; PubMed=20143388). Originally thought to originate from a benign prostatic hyperplasia biopsy from Monroe Vincent one of the authors of the original paper.
Contaminated. Shown to be a SCLC-21H (or SCLC-22H) derivative (PubMed=10508494; PubMed=20143388).
Contaminated. Shown to be a SCLC-21H (or SCLC-22H) derivative (PubMed=10508494; PubMed=20143388).
Contaminated. Shown to be a SCLC-21H (or SCLC-22H) derivative (PubMed=10508494; PubMed=20143388).
Contaminated. Shown to be a SCLC-21H (or SCLC-22H) derivative (PubMed=10508494; PubMed=20143388).
Contaminated. Shown to be a SCLC-21H (or SCLC-22H) derivative (PubMed=10508494; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a CCRF-CEM derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388). Was originally thought to originate from a 17 year old female patient with acute myeloblastic leukemia.
Contaminated. Shown to be a NALM-6 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=10508494; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=16643607; PubMed=20143388). Originally thought to originate from a lung carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=16643607; PubMed=20143388). Originally thought to originate from a lung carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=16643607; PubMed=20143388). Originally thought to originate from a lung carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=6451928; PubMed=20143388). Originally thought to originate from a Wilms tumor.
Contaminated. Shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=6451928; PubMed=20143388). Originally thought to originate from a Wilms tumor.
Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388).
Contaminated. Shown to be a COLO 205 derivative (PubMed=20143388).
Contaminated. Shown to be a COLO 205 derivative (PubMed=20143388).
Contaminated. HEC-155 and HEC-180 have been shown to be identical (PubMed=20143388). Originally thought to originate from a 64 year old female patient with endometrial carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=93571; PubMed=6451928; PubMed=1246601; PubMed=20143388). Originally thought to originate from a prostate carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=93571; PubMed=6451928; PubMed=1246601; PubMed=20143388). Originally thought to originate from a prostate carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=93571; PubMed=6451928; PubMed=1246601; PubMed=20143388). Originally thought to originate from a prostate carcinoma.
Contaminated. Shown to be a WISH derivative (PubMed=11869090; PubMed=20143388). Originally thought to originate from a chorionic villus sample from a 35 year old woman.
Contaminated. Shown to be a WISH derivative (PubMed=11869090; PubMed=20143388). Originally thought to originate from a chorionic villus sample from a 35 year old woman.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=6451928; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=6451928; PubMed=20143388).
Contaminated. Shown to be a HSC-42 derivative (PubMed=20143388). Originally thought to originate from a 45 year old male patient with a stomach carcinoma.
Contaminated. Shown to be a HSC-42 derivative (PubMed=20143388). Originally thought to originate from a 45 year old male patient with a stomach carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to originate from a 4 month old male fetal liver.
Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to originate from a 4 month old male fetal liver.
Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to originate from a 4 month old male fetal liver.
Contaminated. Shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Shown to be a LoVo derivative (PubMed=15771911; PubMed=20143388). Originally thought to originate from a normal colonic mucosa sample.
Contaminated. Shown to be a LoVo derivative (PubMed=15771911; PubMed=20143388). Originally thought to originate from a normal colonic mucosa sample.
Contaminated. Shown to be a COLO 201 derivative (PubMed=20143388).
Contaminated. Shown to be a OCUM-11 derivative (PubMed=20143388). Originally thought to originate from the ascites effusion of a 65 year old male scirrhous gastric cancer patient.
Contaminated. Shown to be a OCUM-11 derivative (PubMed=20143388). Originally thought to originate from the ascites effusion of a 65 year old male scirrhous gastric cancer patient.
Contaminated. Shown to be a OCI-AML-2 derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a OCI-AML-2 derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a OCI-AML-2 derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a OCI-AML-2 derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a OCI-AML-2 derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a OCI-AML-2 derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a OCI-AML-2 derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a OCI-AML-2 derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Was originally thought to originate from a 15 year old female patient with an osteosarcoma.
Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Was originally thought to originate from a 15 year old female patient with an osteosarcoma.
Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Was originally thought to originate from a 15 year old female patient with an osteosarcoma.
Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Was originally thought to originate from a 15 year old female patient with an osteosarcoma.
Contaminated. Shown to be a K-562 derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a 2 year old child suffering from acute megakaryoblastic leukemia (AML-M7).
Contaminated. Shown to be a K-562 derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from the peripheral blood of a 62 year old female patient with chronic myelogenous leukemia.
Contaminated. Shown to be a P3HR-1 derivative (PubMed=6248453; PubMed=20143388). Originally thought to be a tonsillar lymphoid cell line from a male patient with recurrent exudative tonsillitis.
Contaminated. Shown to be a P3HR-1 derivative (PubMed=6248453; PubMed=20143388). Originally thought to be a tonsillar lymphoid cell line from a female patient with recurrent exudative tonsillitis.
Contaminated. Shown to be a RPMI-1788 derivative (PubMed=6248453; PubMed=20143388). Originally thought to be a tonsillar lymphoid cell line from a male patient with recurrent exudative tonsillitis.
Contaminated. Shown to be a Raji derivative (PubMed=6248453; PubMed=20143388). Originally thought to be a tonsillar lymphoid cell line from a female patient with recurrent exudative tonsillitis.
Contaminated. Shown to be a HT-1080 derivative (PubMed=20143388). Originally thought to originate from a prostate carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388). Originally thought to be a transformed Led-30 (CVCL_1E38) cell line.
Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388). Originally thought to be a transformed Led-30 (CVCL_1E38) cell line.
Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388). Originally thought to be a transformed Led-30 (CVCL_1E38) cell line.
Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388). Originally thought to be a transformed Led-30 (CVCL_1E38) cell line.
Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388). Originally thought to be a transformed Led-30 (CVCL_1E38) cell line.
Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a K-562 derivative (PubMed=12412578; PubMed=12592342; PubMed=20143388). Originally thought to originate from the peripheral blood of a 22 year old male patient with chronic myelogenous leukemia.
Contaminated. Shown to be a AML-193 derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a U-937 derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from the peripheral blood of a 57 year old male patient with with monocytic leukemia (M5b).
Contaminated. Shown to be a HeLa derivative (PubMed=58478; PubMed=6451928; PubMed=20143388). Originally thought to originate from a gastric carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=58478; PubMed=6451928; PubMed=20143388). Originally thought to originate from a gastric carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to originate from a prostate carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to originate from a prostate carcinoma.
Contaminated. Shown to be a HCV-29 derivative (PubMed=7905254; PubMed=20143388).
Contaminated. Shown to be a HCV-29 derivative (PubMed=7905254; PubMed=20143388).
Contaminated. Shown to be a HCV-29 derivative (PubMed=7905254; PubMed=20143388).
Contaminated. Shown to be a Reh derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from peripheral blood of a 45 year old male patient with acute lymphoblastic leukemia.
Contaminated. Shown to be a Reh derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from peripheral blood of a 45 year old male patient with acute lymphoblastic leukemia.
Contaminated. Shown to be a K-562 derivative (PubMed=10516762; PubMed=12592342; PubMed=20143388). Originally thought to originate from the bone marrow of a 44 year old female patient with chronic myelogenous leukemia.
Contaminated. Shown to be a K-562 derivative (PubMed=10516762; PubMed=12592342; PubMed=20143388). Originally thought to originate from the bone marrow of a 44 year old female patient with chronic myelogenous leukemia.
Contaminated. Shown to be a U-937 derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a U-937 derivative (PubMed=12592342; PubMed=20143388).
Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=6451928; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=6451928; PubMed=20143388). Originally thought to originate from a breast carcinoma.
Contaminated. Unknown origin but not an umbilical vein endothelium cell line (PubMed=12453433; PubMed=20143388).
Contaminated. Unknown origin but not an umbilical vein endothelium cell line (PubMed=12453433; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388).
Contaminated. Unknown origin but not an umbilical vein endothelium cell line (PubMed=12453433).
Contaminated. Unknown origin but not an umbilical vein endothelium cell line (PubMed=12453433).
Contaminated. Unknown origin but not an umbilical vein endothelium cell line (PubMed=12453433).
Seems to bear part of the HeLa genomic sequence; may be a derivative of HeLa and another cell of unknown origin (PubMed=24991015).
Seems to bear part of the HeLa genomic sequence; may be a derivative of HeLa and another cell of unknown origin (PubMed=24991015).
Seems to bear part of the HeLa genomic sequence; may be a derivative of HeLa and another cell of unknown origin (PubMed=24991015).
Seems to bear part of the HeLa genomic sequence; may be a derivative of HeLa and another cell of unknown origin (PubMed=24991015).
Contaminated. Shown to be a SKG-II-SF derivative (PubMed=20143388). Originally thought to originate from a 50 year old female patient with an uterine large cell non-keratinizing squamous cell carcinoma.
Contaminated. Shown to be a Reh derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a Reh derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a Reh derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a Reh derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388). Originally thought to originate from embryonic lung.
Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388). Originally thought to originate from embryonic lung.
Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388). Originally thought to originate from embryonic lung.
Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388). Originally thought to originate from embryonic lung.
Contaminated. Shown to be a Jurkat derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from the bone marrow of a 60 year old male patient with acute myeloid leukemia.
Contaminated. Shown to be a Jurkat derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from the bone marrow of a 60 year old male patient with acute myeloid leukemia.
Contaminated. Shown to be a Jurkat derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from the bone marrow of a 60 year old male patient with acute myeloid leukemia.
Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4469665; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4469665; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4469665; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4469665; PubMed=20143388).
Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=19344951; PubMed=20143388).
Contaminated. Shown to be a SW480 (or SW620) derivative (BCRC). Originally thought to originate from the lymph nodes of a 67 year old female patient with a gastric carcinoma.
Contaminated. Shown to be a SW480 (or SW620) derivative (BCRC). Originally thought to originate from the lymph nodes of a 67 year old female patient with a gastric carcinoma.
Contaminated. Parent cell line (AZ-521) has been shown to be a Hutu 80 derivative.
Contaminated. Parent cell line (AZ-521) has been shown to be a Hutu 80 derivative.
Contaminated. Parent cell line (AZ-521) has been shown to be a Hutu 80 derivative.
Contaminated. Parent cell line (AZ-521) has been shown to be a Hutu 80 derivative.
Contaminated. Shown to be a HT-29 derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 60 year old male patient gastric carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 60 year old male patient gastric carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 60 year old male patient gastric carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 51 year old male patient gastric carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 51 year old male patient gastric carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 51 year old male patient gastric carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 51 year old male patient gastric carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 66 year old male patient gastric carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 66 year old male patient gastric carcinoma.
Contaminated. Shown to be a HT-29 derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 66 year old male patient gastric carcinoma.
Contaminated. Shown to be a Caki-1 derivative (PubMed=22987579). Originally thought to originate from a 28 year old male HIV-1 negative Kaposi sarcoma patient.
Contaminated. Shown to be a Caki-1 derivative (PubMed=22987579). Originally thought to originate from a 28 year old male HIV-1 negative Kaposi sarcoma patient.
Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=20143388).
Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=20143388).
Partially contaminated. Some stocks are contaminated by VM-CUB-1 (PubMed=3708594; PubMed=20143388). Although PubMed=26621286 shows it to be different from VM-CUB-1.
Partially contaminated. Some stocks are contaminated by VM-CUB-1 (PubMed=3708594; PubMed=20143388). Although PubMed=26621286 shows it to be different from VM-CUB-1.
Partially contaminated. Some stocks are contaminated by VM-CUB-1 (PubMed=3708594; PubMed=20143388). Although PubMed=26621286 shows it to be different from VM-CUB-1.
Partially contaminated. Some stocks are contaminated by VM-CUB-1 (PubMed=3708594; PubMed=20143388). Although PubMed=26621286 shows it to be different from VM-CUB-1.
Partially contaminated. Some stocks are contaminated by VM-CUB-1 (PubMed=3708594; PubMed=20143388). Although PubMed=26621286 shows it to be different from VM-CUB-1.
Partially contaminated. Some stocks are contaminated by VM-CUB-1 (PubMed=3708594; PubMed=20143388). Although PubMed=26621286 shows it to be different from VM-CUB-1.
Partially contaminated. Some stocks are contaminated by VM-CUB-1 (PubMed=3708594; PubMed=20143388). Although PubMed=26621286 shows it to be different from VM-CUB-1.
Partially contaminated. Some stocks are contaminated by VM-CUB-1 (PubMed=3708594; PubMed=20143388). Although PubMed=26621286 shows it to be different from VM-CUB-1.
Partially contaminated. Some stocks are contaminated by VM-CUB-1 (PubMed=3708594; PubMed=20143388). Although PubMed=26621286 shows it to be different from VM-CUB-1.
Partially contaminated. Some stocks are contaminated by VM-CUB-1 (PubMed=3708594; PubMed=20143388). Although PubMed=26621286 shows it to be different from VM-CUB-1.
Contaminated. Shown to be a TPC-1 derivative (PubMed=19087340; PubMed=20143388). Originally thought to originate from a 36 year old female well-differentiated thyroid papillary carcinoma patient.
Contaminated. Shown to be a TPC-1 derivative (PubMed=19087340; PubMed=20143388). Originally thought to originate from a 36 year old female well-differentiated thyroid papillary carcinoma patient.
Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709; PubMed=20143388).
Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709; PubMed=20143388).
Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709; PubMed=20143388).
Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709; PubMed=20143388).
Contaminated. Shown to be a U-937 derivative.
Contaminated. Parent cell line (Tca8113) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (Tca8113) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (Tca8113) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative.
Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative.
Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative.
Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative.
Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative.
Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative.
Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative.
Contaminated. Grand-parent cell line (TE 671) has been shown to be a RD derivative.
Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative.
Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative.
Contaminated. Parent cell line (PC-14) has been shown to be a PC-9 derivative.
Contaminated. Parent cell line (PC-14) has been shown to be a PC-9 derivative.
Contaminated. Parent cell line (PC-14) has been shown to be a PC-9 derivative.
Contaminated. Parent cell line (PC-14) has been shown to be a PC-9 derivative.
Contaminated. Parent cell line (PC-14) has been shown to be a PC-9 derivative.
Contaminated. Parent cell line (PC-14) has been shown to be a PC-9 derivative.
Contaminated. Grand-parent cell line (PC-14) has been shown to be a PC-9 derivative.
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Was originally thought to originate from a 65 year old female patient with a skin basal cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Was originally thought to originate from a 65 year old female patient with a skin basal cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a malignant pleural effusion occurrlng in an 18 year old patient with primary refractory anaplastic large cell lymphoma.
Possibly contaminated. May originate from SK-HEP-1 as 4 other cell lines from the same paper (PubMed=7514905) have been shown to be contaminated.
Contaminated. Shown to be a SK-HEP-1 derivative (PubMed=10508494; PubMed=20143388). Originally thought to be a thymic epithelial cell line from a 9 week old fetal thymus.
Contaminated. Shown to be a SK-HEP-1 derivative (PubMed=10508494; PubMed=20143388). Originally thought to be a thymic epithelial cell line from a 9 week old fetal thymus.
Contaminated. Shown to be a SK-HEP-1 derivative (PubMed=10508494; PubMed=20143388). Originally thought to be a thymic epithelial cell line from a 9 week old fetal thymus.
Contaminated. Shown to be a SK-HEP-1 derivative (PubMed=10508494; PubMed=20143388). Originally thought to be a thymic epithelial cell line from a 9 week old fetal thymus.
Contaminated. Shown to be a SK-HEP-1 derivative (PubMed=10508494; PubMed=20143388).
Contaminated. Shown to be a SK-HEP-1 derivative (PubMed=10508494; PubMed=20143388).
Possibly contaminated. May originate from SK-HEP-1 as 4 other cell lines from the same paper (PubMed=7514905) have been shown to be contaminated.
Possibly contaminated. May originate from SK-HEP-1 as 4 other cell lines from the same paper (PubMed=7514905) have been shown to be contaminated.
Possibly contaminated. May originate from SK-HEP-1 as 4 other cell lines from the same paper (PubMed=7514905) have been shown to be contaminated.
Contaminated. Shown to be a SK-HEP-1 derivative (PubMed=10508494; PubMed=20143388). Originally thought to be a thymic epithelial cell line from a 6 month old baby thymus.
Contaminated. Shown to be a SK-HEP-1 derivative (PubMed=10508494; PubMed=20143388). Originally thought to be a thymic epithelial cell line from a 6 month old baby thymus.
Contaminated. Parent cell line (HSG) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Parent cell line (HSG) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Parent cell line (HSG) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Parent cell line (HSG) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Parent cell line (HSG) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Parent cell line (HSG) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Parent cell line (HSG) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Shown to be a Reh derivative (PubMed=12200708; PubMed=12592342; PubMed=20143388; PubMed=24923861). Originally thought to originate from a 68 year old male patient with chronic lymphocytic leukemia.
Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
Contaminated. Shown to be a ME-180 derivative (BCRC and STR profile). Originally thought to originate from a 56 year old male patient with a grade 2, stage A papillary transitional cell carcinoma.
Contaminated. Shown to be a ME-180 derivative (BCRC and STR profile). Originally thought to originate from a 56 year old male patient with a grade 2, stage A papillary transitional cell carcinoma.
Contaminated. Shown to be a ME-180 derivative (BCRC and STR profile). Originally thought to originate from a 56 year old male patient with a grade 2, stage A papillary transitional cell carcinoma.
Contaminated. Shown to be a ME-180 derivative (BCRC and STR profile). Originally thought to originate from a 56 year old male patient with a grade 2, stage A papillary transitional cell carcinoma.
Possibly misidentified/contaminated. Reported by PubMed=11787853 to contain the same HPV18 sequences as the cervix carcinoma cell line C-4-I (CVCL_2253) and to lack mutations in KRAS, TP53, CDKN2A and DPC4 often found in pancreatic adenocarcinoma. Considered by PubMed=25997541 to be a bladder carcinoma cell line.
Possibly misidentified/contaminated. Reported by PubMed=11787853 to contain the same HPV18 sequences as the cervix carcinoma cell line C-4-I (CVCL_2253) and to lack mutations in KRAS, TP53, CDKN2A and DPC4 often found in pancreatic adenocarcinoma. Considered by PubMed=25997541 to be a bladder carcinoma cell line.
Possibly misidentified/contaminated. Reported by PubMed=11787853 to contain the same HPV18 sequences as the cervix carcinoma cell line C-4-I (CVCL_2253) and to lack mutations in KRAS, TP53, CDKN2A and DPC4 often found in pancreatic adenocarcinoma. Considered by PubMed=25997541 to be a bladder carcinoma cell line.
Contaminated. Shown to be a C-33 A derivative (PubMed=22710073).
Contaminated. Shown to be a C-33 A derivative (PubMed=22710073).
Contaminated. Shown to be a C-33 A derivative (PubMed=22710073).
Partially contaminated. Some cultures of NCI-H1339 are contaminated with NCI-H157 or NCI-1264 (PubMed=25877200).
Partially contaminated. Some cultures of NCI-H1339 are contaminated with NCI-H157 or NCI-1264 (PubMed=25877200).
Partially contaminated. Some cultures of NCI-H1339 are contaminated with NCI-H157 or NCI-1264 (PubMed=25877200).
Partially contaminated. Some cultures of NCI-H1339 are contaminated with NCI-H157 or NCI-1264 (PubMed=25877200).
Contaminated. Shown to be a NCI-H69 derivative (PubMed=20143388).
Contaminated. Shown to be a NCI-H69 derivative (PubMed=20143388).
Contaminated. Shown to be a NCI-H69 derivative (PubMed=20143388).
Contaminated. Shown to be a NCI-H69 derivative (PubMed=20143388).
Contaminated. Shown to be a NCI-H125 derivative. Originally thought to originate with the pleural effusion of a mesothelioma in a 64 year old male patient.
Contaminated. Shown to be a NCI-H125 derivative. Originally thought to originate with the pleural effusion of a mesothelioma in a 64 year old male patient.
Contaminated. Shown to be a NCI-H125 derivative. Originally thought to originate with the pleural effusion of a mesothelioma in a 64 year old male patient.
Contaminated. Shown to be a NCI-H125 derivative. Originally thought to originate with the pleural effusion of a mesothelioma in a 64 year old male patient.
Contaminated. Shown to be a NCI-H125 derivative. Originally thought to originate with the pleural effusion of a mesothelioma in a 64 year old male patient.
Contaminated. Shown to be a NCI-H69 derivative.
Contaminated. Shown to be a NCI-H69 derivative.
Contaminated. Shown to be a NCI-H69 derivative.
Contaminated. Shown to be a NCI-H69 derivative.
Contaminated. Shown to be a NCI-H69 derivative.
Contaminated. Shown to be a NCI-H69 derivative.
Contaminated. Shown to be a NCI-H69 derivative.
Contaminated. Shown to be a NCI-N417 derivative.
Contaminated. Shown to be a NCI-N417 derivative.
Contaminated. Shown to be a NCI-N417 derivative.
Contaminated. Shown to be a 647V derivative (PubMed=23472229). Originally thought to originate from a thyroid gland medullary carcinoma.
Contaminated. Shown to be a 647V derivative (PubMed=23472229). Originally thought to originate from a thyroid gland medullary carcinoma.
Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
Probably contaminated. The STR profile is identical to that of the SK-N-AS cell line. Originally thought to originate from a neuroblastoma but the gender and age of the patient has not been reported.
Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
Misidentified. This cell line was mistakenly distributed by OCI to a number of groups as being OCI-Ly-3 (CVCL_8800). The real identity of this cell line is not known. From personal communication of Neve R.
Misidentified. This cell line was mistakenly distributed by OCI to a number of groups as being OCI-Ly-3 (CVCL_8800). The real identity of this cell line is not known. From personal communication of Neve R.
Probably contaminated. Shown to be a Caki-1 derivative (based on STR profile).
Probably contaminated. Shown to be a Caki-1 derivative (based on STR profile).
Probably contaminated. Shown to be a Caki-1 derivative (based on STR profile).
Probably contaminated. Shown to be a Caki-1 derivative (based on STR profile).
Partially contaminated. Some stocks are contaminated by UM-SCC-1 (PubMed=21868764).
Partially contaminated. Some stocks are contaminated by UM-SCC-1 (PubMed=21868764).
Partially contaminated. Some stocks are contaminated by UM-SCC-1 (PubMed=21868764).
Probably contaminated. The STR profile is identical to that of the T24 cell line.
Contaminated. The stock of COLO 720E distributed by ECACC was contaminated by COLO 704 (PubMed=25230021; PubMed=25877200).
Contaminated. Shown to be a HeLa derivative (PubMed=20143388; PubMed=29923277). Originally thought to originate from a 51 year old female patient with a parotid gland adenocarcinoma.
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative (PubMed=20143388). Was first thought to originate from the femoral metastasis of a breast carcinoma but was later shown to be contaminated by MDA-MB-435 (PubMed=15679051).
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative (PubMed=20143388). Was first thought to originate from the femoral metastasis of a breast carcinoma but was later shown to be contaminated by MDA-MB-435 (PubMed=15679051).
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative (PubMed=20143388). Was first thought to originate from the femoral metastasis of a breast carcinoma but was later shown to be contaminated by MDA-MB-435 (PubMed=15679051).
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Ancestral cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Ancestral cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin.
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin.
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin.
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin.
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin.
Contaminated. Shown to be a U-251MG derivative. Originally thought to originate from a 22 year old female patient with glioblastoma.
Misidentified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be a T lymphoblastic lymphoma (PubMed=29533902).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be a T lymphoblastic lymphoma (PubMed=29533902).
Contaminated. Parent cell line (YMB-1) has been shown to be a ZR-75-1 derivative.
Possibly misidentified. It is not certain that this cell line originate from a hairy cell leukemia (PubMed=22653958).
Possibly misidentified. It is not certain that this cell line originate from a hairy cell leukemia (PubMed=22653958).
Possibly misidentified. It is not certain that this cell line originate from a hairy cell leukemia (PubMed=22653958).
Possibly misidentified. It is not certain that this cell line originate from a hairy cell leukemia (PubMed=22653958).
Possibly misidentified. It is not certain that this cell line originate from a hairy cell leukemia (PubMed=22653958).
Contaminated. Shown to be a PC-3 derivative (PubMed=21868764). Originally thought to originate from a oropharyngeal squamous cell carcinoma.
Contaminated. Shown to be a PC-3 derivative (PubMed=21868764). Originally thought to originate from a oropharyngeal squamous cell carcinoma.
Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342; PubMed=20143388). Was orginally thought to originates from the bone marrow of a patient suffering fron neuroblastoma that evolved into a Hodgkin lymphoma.
Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342; PubMed=20143388). Was orginally thought to originates from the bone marrow of a patient suffering fron neuroblastoma that evolved into a Hodgkin lymphoma.
Contaminated. Parent cell line (YMB-1) has been shown to be a ZR-75-1 derivative.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4472134; PubMed=20143388). Originally thought to originate from a 41 year old patient with astrocytoma.
Contaminated. Shown to be a HeLa derivative (PubMed=557237; PubMed=6451928; PubMed=20143388). Originally thought to originate from a ductal breast carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=557237; PubMed=6451928; PubMed=20143388). Originally thought to originate from a ductal breast carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=557237; PubMed=6451928; PubMed=20143388). Originally thought to originate from a ductal breast carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4469665; PubMed=20143388). Originally thought to originate from a breast carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4469665; PubMed=20143388). Originally thought to originate from a breast carcinoma.
Contaminated. Shown to be a MIA PaCa-2 derivative (PubMed=20143388).
Contaminated. Shown to be a MIA PaCa-2 derivative (PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=6451928; PubMed=20143388). Originally thought to originate from a prostate carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=6451928: PubMed=20143388). Originally thought to originate from a rectal adenocarcinoma.
Contaminated. Parent cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Parent cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4472134; PubMed=20143388).
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Shown to be a OVCAR-8 derivative (PubMed=22710073).
Contaminated. Shown to be a OVCAR-8 derivative (PubMed=22710073).
Contaminated. Shown to be a OVCAR-8 derivative (PubMed=22710073).
Contaminated. Shown to be a OVCAR-8 derivative (PubMed=22710073).
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Contaminated. Shown to be a HT-29 derivative (PubMed=15703300; resulting in a decision not to include the cell line in the NCI60 panel).
Contaminated. Shown to be a HT-29 derivative (PubMed=15703300; resulting in a decision not to include the cell line in the NCI60 panel).
Contaminated. Shown to be a HT-29 derivative (PubMed=15703300; resulting in a decision not to include the cell line in the NCI60 panel).
Contaminated. Shown to be a HT-29 derivative (PubMed=15703300; resulting in a decision not to include the cell line in the NCI60 panel).
Contaminated. Shown to be a KU-SN derivative (PubMed=20143388).
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin.
Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin. Originally thought to originate from an acute myelocytic leukemia (RCB).
Contaminated. From its STR profile the parent cell line (SC) seems to be a U-937 derivative.
Contaminated. From its STR profile the parent cell line (SC) seems to be a U-937 derivative.
Contaminated. Shown to be a COLO 320DM derivative.
Contaminated. Shown to be a COLO 320DM derivative.
Contaminated. Shown to be a COLO 320DM derivative.
Contaminated. Shown to be a SK-OV-3 derivative. Originally thought to originate from an HPV16 immortalized first trimester placenta.
Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 63 year old female patient with a meningioma.
Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 63 year old female patient with a meningioma.
Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 63 year old female patient with a meningioma.
Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 86 year old female patient with a breast adenocarcinoma.
Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 86 year old female patient with a breast adenocarcinoma.
Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 86 year old female patient with a breast adenocarcinoma.
Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 67 year old female patient with a cervical squamous cell carcinoma metastasized to the lung.
Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 67 year old female patient with a cervical squamous cell carcinoma metastasized to the lung.
Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 67 year old female patient with a cervical squamous cell carcinoma metastasized to the lung.
Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 69 year old female patient with a bladder transitional cell carcinoma.
Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 69 year old female patient with a bladder transitional cell carcinoma.
Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 69 year old female patient with a bladder transitional cell carcinoma.
Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 55 year old female patient with a fibrillary astrocytoma.
Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 55 year old female patient with a fibrillary astrocytoma.
Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 55 year old female patient with a fibrillary astrocytoma.
Contaminated. Shown to be a T24 derivative (PubMed=22987579). Was thought to originate from the pleural effusion of a male AIDS patient with Kaposi sarcoma.
Contaminated. Shown to be a T24 derivative (PubMed=22987579). Was thought to originate from the pleural effusion of a male AIDS patient with Kaposi sarcoma.
Contaminated. Shown to be a T24 derivative (PubMed=22987579). Was thought to originate from the pleural effusion of a male AIDS patient with Kaposi sarcoma.
Contaminated. Shown to be a Flow1000 derivative.
Contaminated. Shown to be a Flow1000 derivative.
Contaminated. Shown to be a MRC-5 derivative (PubMed=20143388).
Contaminated. Shown to be a MRC-5 derivative (PubMed=20143388).
Contaminated. Grand-parent cell line (Ej138) has been shown to be a T24 derivative.
Contaminated. Grand-parent cell line (Ej138) has been shown to be a T24 derivative.
Contaminated. Grand-parent cell line (Ej138) has been shown to be a T24 derivative.
Possibly contaminated. The STR profile is very similar to that of the HelA cell line and almost identical to that of HNE-1 (CVCL_0308).
Possibly contaminated. The STR profile is very similar to that of the HelA cell line and almost identical to that of HNE-1 (CVCL_0308).
Misidentified. Originally thought to originate from an osteosarcoma and is now identified as a neuroblastoma cell line (PubMed=22415601; PubMed=24046071).
Contaminated. Shown to be a NCI-H23 derivative (PubMed=25877200). Originally thought to originate from a 26 year old female patient with an ovarian cystadenocarcinoma.
Contaminated. Shown to be a NCI-H23 derivative (PubMed=25877200). Originally thought to originate from a 26 year old female patient with an ovarian cystadenocarcinoma.
Contaminated. Shown to be a Hs 633.T derivative (PubMed=2902939).
Contaminated. Shown to be a Hs 633.T derivative (PubMed=2902939). Originally thought to originate from the chemical transformation of KD (CVCL_2970) fibroblast cells.
Contaminated. Shown to be a Hs 633.T derivative (PubMed=2902939). Originally thought to originate from the chemical transformation of KD (CVCL_2970) fibroblast cells.
Contaminated. Shown to be a Hs 633.T derivative (PubMed=2902939). Originally thought to originate from the chemical transformation of KD (CVCL_2970) fibroblast cells.
Contaminated. Shown to be a Hs 633.T derivative (PubMed=2902939). Originally thought to originate from the chemical transformation of KD (CVCL_2970) fibroblast cells.
Contaminated. Shown to be a Jurkat derivative (DOI=10.1016/j.leukres.2012.09.007, ICLAC). Originally thought to be of dog origin and to originate from a lymphoma from a female Bullmastiff.
Contaminated. Shown to be a Jurkat derivative (DOI=10.1016/j.leukres.2012.09.007, ICLAC). Originally thought to be of dog origin and to originate from a lymphoma from a male German Shorthaired Pointer.
Contaminated. Shown to be a Jurkat derivative (DOI=10.1016/j.leukres.2012.09.007, ICLAC). Originally thought to be of dog origin and to originate from a lymphoma from a male Labrador Retriever.
Contaminated. Shown to be a Jurkat derivative (DOI=10.1016/j.leukres.2012.09.007, ICLAC). Originally thought to be of dog origin and to originate from a lymphoma from a male Basset Hound.
Contaminated. Shown to be a Jurkat derivative (DOI=10.1016/j.leukres.2012.09.007, ICLAC). Originally thought to be of dog origin and to originate from a lymphoma from a male Greyhound.
Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative.
Contaminated. Shown to be a PF-382 derivative. Originally thought to originate from the axillary lymph node biopsy of a 12 year old boy with a T-cell malignant lymphoma.
Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Ancestral cell line (Ej138) has been shown to be a T24 derivative.
Contaminated. Ancestral cell line (Ej138) has been shown to be a T24 derivative.
Misidentified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Grand-parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Grand-parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Grand-parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Grand-parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (KKU-M214) shown to be a KKU-M213 derivative.
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (BEL-7404) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (BEL-7404) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (BEL-7404) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (BEL-7404) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (BEL-7404) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (BEL-7404) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (BEL-7404) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (BEL-7404) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (BEL-7404) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (BEL-7404) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (BEL-7404) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (BEL-7404) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (PC-14) has been shown to be a PC-9 derivative.
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=20143388).
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=20143388).
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=20143388).
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=20143388).
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=20143388).
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=20143388).
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=20143388).
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=20143388).
Contaminated. Parent cell line (SKW-3) has been shown to be a KE-37 derivative.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
Contaminated. Parent cell line (ECV-304) has been shown to be a T24 derivative.
Contaminated. Grand-parent cell line (ECV-304) has been shown to be a T24 derivative.
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Shown to be a K-562 derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a patient with malignant histiocytosis in the leukemic stage.
Contaminated. Shown to be a HeLa derivative (PubMed=884688; PubMed=1246601; PubMed=4469665; PubMed=6451928; PubMed=20143388). Originally thought to originate from a breast carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=884688; PubMed=1246601; PubMed=4469665; PubMed=6451928; PubMed=20143388). Originally thought to originate from a breast carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=884688; PubMed=1246601; PubMed=4469665; PubMed=6451928; PubMed=20143388). Originally thought to originate from a breast carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=884688; PubMed=1246601; PubMed=4469665; PubMed=6451928; PubMed=20143388). Originally thought to originate from a breast carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=884688; PubMed=1246601; PubMed=4469665; PubMed=6451928; PubMed=20143388). Originally thought to originate from a breast carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=884688; PubMed=1246601; PubMed=4469665; PubMed=6451928; PubMed=20143388). Originally thought to originate from a breast carcinoma.
Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12581897; PubMed=12592342; PubMed=20143388). Originally thought to originate from the lymph node biopsy of a patient with Hodgkin lymphoma.
Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12581897; PubMed=12592342; PubMed=20143388). Originally thought to originate from the lymph node biopsy of a patient with Hodgkin lymphoma.
Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12581897; PubMed=12592342; PubMed=20143388). Originally thought to originate from the lymph node biopsy of a patient with Hodgkin lymphoma.
Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12581897; PubMed=12592342; PubMed=20143388). Originally thought to originate from the lymph node biopsy of a patient with Hodgkin lymphoma.
Misidentified. Originally thought to derive from Hs 766T but was later (erratum) shown to be derived from RKO (PubMed=12082016).
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (OVCAR-5) originally thought to be a high grade ovarian serous adenocarcinoma but suspected to have a upper gastrointestinal origin.
Contaminated. Parent cell line (ECV-304) has been shown to be a T24 derivative.
Contaminated. Parent cell line (ECV-304) has been shown to be a T24 derivative.
Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Shown to be a HT-29 derivative (ICLAC; an early sample of KM20 had been tested by the core facility where the cell line was established and the STR profile corresponds to that of HT-29).
Contaminated. Shown to be a HT-29 derivative (ICLAC; an early sample of KM20 had been tested by the core facility where the cell line was established and the STR profile corresponds to that of HT-29).
Contaminated. Shown to be a U-937 derivative.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=6451928; PubMed=20143388).
Possibly misidentified: Not certain if this a midgut carcinoid cell line (PubMed=20959409).
Possibly misidentified: Not certain if this a midgut carcinoid cell line (PubMed=20959409).
Contaminated. Shown to be a HK derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a separate patient (68 year old female) than HK (male).
Contaminated. Shown to be a K-562 derivative (PubMed=11871388; PubMed=12592342; PubMed=20143388).
Contaminated. Shown to be a Jurkat derivative (PubMed=12592342; PubMed=19344951; PubMed=20143388).
Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from the peripheral blood of an adult male with acute myelomonocytic leukemia.
Contaminated. Parent cell line (BLIN-1) has been shown to be a NALM-6 derivative (PubMed=20143388).
Misidentified/contaminated. The STR profile matches the wrong donor (EBiSC).
Misidentified/contaminated. The STR profile matches the wrong donor (EBiSC).
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a 33 year old female patient with ovarian mucinous cystadenocarcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a 33 year old female patient with ovarian mucinous cystadenocarcinoma.
Contaminated. Shown to be a RD derivative (personal communication of Millipore). Originally thought to be a MG-63 derivative.
Contaminated. Parent cell line (Ej138) has been shown to be a T24 derivative.
Contaminated. Parent cell line (Ej138) has been shown to be a T24 derivative.
Contaminated. Grand-parent cell line (Ej138) has been shown to be a T24 derivative.
Contaminated. Grand-parent cell line (Ej138) has been shown to be a T24 derivative.
Contaminated. Grand-parent cell line (Ej138) has been shown to be a T24 derivative.
Contaminated. Grand-parent cell line (Ej138) has been shown to be a T24 derivative.
Contaminated. Ancestral cell line (Ej138) has been shown to be a T24 derivative.
Contaminated. Ancestral cell line (Ej138) has been shown to be a T24 derivative.
Contaminated. Parent cell line (Ej138) has been shown to be a T24 derivative.
Contaminated. Grand-parent cell line (Ej138) has been shown to be a T24 derivative.
Misidentified. Originally thought to be a chordoma cell line but is either contaminated or established from nonchordoma cells (PubMed=21253487).
Misidentified. Originally thought to be a chordoma cell line but is either contaminated or established from nonchordoma cells (PubMed=21253487).
Contaminated. Shown to be a HeLa derivative (on the basis of the STR profile of PubMed=21253487). Originally thought to originate from a 42 year old male patient with chordoma.
Contaminated. Shown to be a HeLa derivative (on the basis of the STR profile of PubMed=21253487). Originally thought to originate from a 42 year old male patient with chordoma.
Misidentified. Originally thought to be a chordoma cell line but is either contaminated or established from nonchordoma cells (PubMed=21253487).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4472134; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4472134; PubMed=20143388). Originally thought to be a derivative of WI-38.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4472134; PubMed=20143388). Originally thought to be a derivative of WI-38.
Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (TSU-Pr1) has been shown to be a T24 derivative.
Contaminated. Parent cell line (TSU-Pr1) has been shown to be a T24 derivative.
Contaminated. Parent cell line (TSU-Pr1) has been shown to be a T24 derivative.
Contaminated. Parent cell line (BEL-7402) has been shown to be a HeLa derivative.
Contaminated. Shown to be a KKU-M213 derivative (see JCRB web site).
Contaminated. Shown to be a KKU-M213 derivative (see JCRB web site).
Contaminated. Shown to be a KKU-M213 derivative (see JCRB web site).
Contaminated. Shown to be a KKU-M213 derivative (see JCRB web site).
Contaminated. Shown to be a KKU-M213 derivative (see JCRB web site).
Contaminated. Shown to be a KKU-M213 derivative (see JCRB web site).
Contaminated. Shown to be a KKU-M213 derivative (see JCRB web site).
Contaminated. Shown to be a KKU-M213 derivative (see JCRB web site).
Contaminated. Shown to be a KKU-M213 derivative (see JCRB web site).
Retracted. The paper reporting this cell line (PubMed=14963337) has been retracted due to fraud (see PubMed=16410485).
Retracted. The paper reporting this cell line (PubMed=14963337) has been retracted due to fraud (see PubMed=16410485).
Retracted. The paper reporting this cell line (PubMed=14963337) has been retracted due to fraud (see PubMed=16410485).
Retracted. The paper reporting this cell line (PubMed=14963337) has been retracted due to fraud (see PubMed=16410485).
Retracted. The paper reporting this cell line (PubMed=14963337) has been retracted due to fraud (see PubMed=16410485).
Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
Contaminated. Parent cell line (QGY-7703) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (QGY-7703) has been shown to be a HeLa derivative.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=6451928; PubMed=20143388). Originally thought to originate from the pleural effusion of a female patient with breast carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=6451928; PubMed=20143388). Originally thought to originate from the pleural effusion of a female patient with breast carcinoma.
Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=10936422).
Parent cell line (HONE-1) seems to bear part of the HeLa genomic sequence and may be a derivative of HeLa and another cell of unknown origin.
Parent cell line (HONE-1) seems to bear part of the HeLa genomic sequence and may be a derivative of HeLa and another cell of unknown origin.
Parent cell line (HONE-1) seems to bear part of the HeLa genomic sequence and may be a derivative of HeLa and another cell of unknown origin.
Parent cell line (HONE-1) seems to bear part of the HeLa genomic sequence and may be a derivative of HeLa and another cell of unknown origin.
Contaminated. Parent cell line (Detroit 6) has been shown to be a HeLa derivative (PubMed=6451928; PubMed=1246601).
Contaminated. Parent cell line (Detroit 6) has been shown to be a HeLa derivative (PubMed=6451928; PubMed=1246601).
Contaminated. Parent cell line (Detroit 6) has been shown to be a HeLa derivative (PubMed=6451928; PubMed=1246601).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
Contaminated. Parent cell line (JHC) has been shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=6451928; PubMed=20143388). Originally thought to originate from the pleural effusion of a female patient with breast carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=6451928; PubMed=20143388). Originally thought to originate from the pleural effusion of a female patient with breast carcinoma.
Contaminated. Parent cell line (L-132) has been shown to be a HeLa derivative (PubMed=1246601).
Contaminated. Parent cell line (L-132) has been shown to be a HeLa derivative (PubMed=1246601).
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4469665; PubMed=20143388). Originally thought to originate from an embryonic kidney.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4469665; PubMed=20143388). Originally thought to originate from an embryonic kidney.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4469665; PubMed=20143388). Originally thought to originate from an embryonic kidney.
Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4469665; PubMed=20143388). Originally thought to originate from an embryonic kidney.
Contaminated. Parent cell line (HEK) has been shown to be a HeLa derivative (PubMed=1246601; PubMed=4469665; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative. Originally thought to originate from a male patient lung adenocarcinoma. The original MAC-21 cell line was never tested for contamination. See the colorful description of the MAC-21 contamination story in the book from Michael Gold (CLPUB00262).
Contaminated. Shown to be a HeLa derivative. Originally thought to originate from a male patient lung adenocarcinoma. The original MAC-21 cell line was never tested for contamination. See the colorful description of the MAC-21 contamination story in the book from Michael Gold (CLPUB00262).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line but is a B-lymphoblastoid cell line (PubMed=12592342).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line but is a B-lymphoblastoid cell line (PubMed=12592342).
Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388). Originally thought to originate from a male patient lung adenocarcinoma. The 2563 cell line is said to be derived from the MAC-21 cell line (CVCL_M627) which is also HeLa contaminated but which has never been tested for such a contamination.
Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388). Originally thought to originate from fetal lung.
Contaminated. Shown to be a Pfeiffer derivative (PubMed=23907998) and not a mucosa-associated lymphoid tissue (MALT) lymphoma cell line. This finding is disputed by the original authors (see PubMed=24285409).
Contaminated. Shown to be a Pfeiffer derivative (PubMed=23907998) and not a mucosa-associated lymphoid tissue (MALT) lymphoma cell line. This finding is disputed by the original authors (see PubMed=24285409).
Contaminated. Shown to be a T24 derivative (PubMed=23691160).
Contaminated. Parent cell line (HBT-3) has been shown to be a HeLa derivative (PubMed=1246601; PubMed=4469665; PubMed=20143388).
Contaminated. Parent cell line (HBT-3) has been shown to be a HeLa derivative (PubMed=1246601; PubMed=4469665; PubMed=20143388).
Contaminated. Parent cell line (HBT-3) has been shown to be a HeLa derivative (PubMed=1246601; PubMed=4469665; PubMed=20143388).
Contaminated. Shown to be a HT-29 derivative (PubMed=23472229). Originally thought to originate from a thyroid gland medullary carcinoma.
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
Contaminated. Shown to be a HeLa derivative (PubMed=7394535; PubMed=20143388). Originally thought to originate from the kidney of a 8 year old boy.
Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388).
Contaminated. Parent cell line (KU-7) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (TSU-Pr1) has been shown to be a T24 derivative.
Contaminated. Grand-parent cell line (TSU-Pr1) has been shown to be a T24 derivative.
Contaminated. Parent cell line (41M) has been shown to be a OAW28 derivative.
Contaminated. Parent cell line (41M) has been shown to be a OAW28 derivative.
Contaminated. Parent cell line (41M) has been shown to be a OAW28 derivative.
Contaminated. Parent cell line (MKN28) has been shown to be a MKN74 derivative.
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
Contaminated. Parent cell line (SGC-7901) has been shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from the lymph node of a 56 year old female patient with a gastric carcinoma.
Contaminated. Parent cell line (SGC-7901) has been shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from the lymph node of a 56 year old female patient with a gastric carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from embryonic lung fibroblasts.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from embryonic lung fibroblasts.
Possibly misidentified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be either a B-cell non-Hodgkin lymphoma or a diffuse large B-cell lymphoma (PubMed=29533902).
Contaminated. Parent cell line (LN-319) has been shown to be a LN-992 derivative.
Contaminated. Parent cell line (LN-319) has been shown to be a LN-992 derivative.
Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile.
Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile.
Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile.
Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile.
Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile.
Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile.
Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile.
Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile.
Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile.
Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile.
Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile.
Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile.
Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile.
Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile.
Possibly contaminated. STR profile is highly similar to that of HCT-116.
Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (MOBS-1) has been shown to be a U-937 derivative.
Possibly misidentified. The sister cell line CTV-1 was originally thought to be a acute monoblastic leukemia but seems to be a T-ALL cell line. CTV-1 was also said to originate from a 40 year old female patient but has a male STR profile.
Possibly misidentified: Not certain if this a human or mouse cell line.
Contaminated. Parent cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Parent cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Parent cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Parent cell line (NC-37) has been shown to be a Raji derivative.
Contaminated. Shown to be a Y-79 derivative (PubMed=1679230). Originally thought to originate from a 2 year old boy with bilateral retinoblastoma.
Contaminated. Shown to be a Y-79 derivative (PubMed=1679230). Originally thought to originate from a 2 year old boy with bilateral retinoblastoma.
Contaminated. Shown to be a Y-79 derivative (PubMed=1679230). Originally thought to originate from a 2 year old boy with bilateral retinoblastoma.
Contaminated. Shown to be a Y-79 derivative (PubMed=1679230). Originally thought to originate from a 2 year old boy with bilateral retinoblastoma.
Contaminated. Shown to be a Y-79 derivative (PubMed=1679230). Originally thought to originate from a 2 year old boy with bilateral retinoblastoma.
Contaminated. Shown to be a Y-79 derivative (PubMed=1679230). Originally thought to originate from a male retinoblastoma patient.
Contaminated. Shown to be a Y-79 derivative (PubMed=1679230). Originally thought to originate from a male retinoblastoma patient.
Contaminated. Shown to be a NCI-H295R derivative (PubMed=21924324). Originally thought to originate from a 11 month old female patient with adrenal cortex carcinoma.
Contaminated. Shown to be a NCI-H295R derivative (PubMed=21924324). Originally thought to originate from a 11 month old female patient with adrenal cortex carcinoma.
Contaminated. Shown to be a NCI-H295R derivative (PubMed=21924324). Originally thought to originate from a 11 month old female patient with adrenal cortex carcinoma.
Misidentified. Originally thought to be a seminoma cell line but shown not to be from germ cells. Its real nature is not clear (PubMed=17705808; PubMed=18008088).
Misidentified. Originally thought to be a seminoma cell line but shown not to be from germ cells. Its real nature is not clear (PubMed=17705808; PubMed=18008088).
Misidentified. Parent cell line (JKT-1) was originally thought to be a seminoma cell line but shown not to be from germ cells. Its real nature is not clear (PubMed=17705808; PubMed=18008088).
Contaminated. Shown to be a LS513 derivative (ICLAC). Originally thought to originate from the ascitic fluid of a 55 year old female patient with triple-negative breast carcinoma.
Contaminated. Parent cell line (Tca8113) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Parent cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Parent cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Parent cell line (U-118MG) has been shown to be a U-138MG derivative.
Contaminated. Shown to be a PHK16-0b derivative (PubMed=20143388).
Probably contaminated. The STR profile is identical to that of the RD-ES cell line. Originally thought to originate from a giant cell tumor excised in 1986 from tumor tissue of a 41 year old female patient.
Probably contaminated. The STR profile is identical to that of the RD-ES cell line. Originally thought to originate from a giant cell tumor excised in 1986 from tumor tissue of a 41 year old female patient.
Contaminated. Parent cell line (HSY) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Parent cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Parent cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=20143388).
Contaminated. Parent cell line (HBT-3) has been shown to be a HeLa derivative (PubMed=884688; PubMed=6451928; PubMed=20143388).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line but shown not be the case although the origin of this cell line is still not known (PubMed=7192801; PubMed=12592342; PubMed=20143388).
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Possibly contaminated. Parent cell lines (MGC-803) seems to be a derivative of HeLa and another cell of unknown origin. The STR profile of MGC-803 is highly similar to that of HeLa yet shows some specific differences that suggest a possible hybrid cell line.
Possibly contaminated. Parent cell lines (MGC-803) seems to be a derivative of HeLa and another cell of unknown origin. The STR profile of MGC-803 is highly similar to that of HeLa yet shows some specific differences that suggest a possible hybrid cell line.
Possibly contaminated. Parent cell lines (MGC-803) seems to be a derivative of HeLa and another cell of unknown origin. The STR profile of MGC-803 is highly similar to that of HeLa yet shows some specific differences that suggest a possible hybrid cell line.
Misidentified. Parent cell line (OVCAR-5) originally thought to be a high grade ovarian serous adenocarcinoma but suspected to have a upper gastrointestinal origin.
Misidentified. Parent cell line (OVCAR-5) originally thought to be a high grade ovarian serous adenocarcinoma but suspected to have a upper gastrointestinal origin.
Contaminated. Parent cell line (HPB-MLT) has been shown to be a HPB-ALL derivative.
Contaminated. Parent cell line (HPB-MLT) has been shown to be a HPB-ALL derivative.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Contaminated. Parent cell line (MKN28) has been shown to be a MKN74 derivative.
Contaminated. Parent cell line (SLR20) has been shown to be a T24 derivative.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from an esophageal squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from an esophageal squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from an esophageal squamous cell carcinoma.
Contaminated. Parent cell line (ECV-304) has been shown to be a T24 derivative.
Contaminated. Parent cell line (SCCTF) has been shown to be a SCCKN derivative.
Contaminated. Parent cell line (SCCTF) has been shown to be a SCCKN derivative.
Contaminated. Parent cell line (SCCTF) has been shown to be a SCCKN derivative.
Contaminated. Parent cell line (SCCTF) has been shown to be a SCCKN derivative.
Contaminated. Shown to be a TPC-1 derivative (PubMed=21868764).
Contaminated. Shown to be a T24 derivative (ICLAC). Originally thought to originate from a clear cell renal cell carcinoma.
Contaminated. Shown to be a T24 derivative (ICLAC). Originally thought to originate from a clear cell renal cell carcinoma.
Contaminated. Shown to be a RCC4 derivative (ICLAC).
Contaminated. Shown to be a RCC4 derivative (ICLAC).
Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
Contaminated. Parent cell line (NCI-H157) has been shown to be identical to NCI-H1264.
Contaminated. Parent cell line (NCI-H157) has been shown to be identical to NCI-H1264.
Probably misidentified. This cell line is said to originate from the same individual as ZZUi002-A but the STR profiles of these two cell lines are completely different.
Probably misidentified. This cell line is said to originate from the same individual as ZZUi002-A but the STR profiles of these two cell lines are completely different.
Probably misidentified. This cell line is said to originate from the same individual as ZZUi001-A but the STR profiles of these two cell lines are completely different.
Probably misidentified. This cell line is said to originate from the same individual as ZZUi001-A but the STR profiles of these two cell lines are completely different.
Possibly contaminated. Parent cell lines (MGC-803) seems to be a derivative of HeLa and another cell of unknown origin. The STR profile of MGC-803 is highly similar to that of HeLa yet shows some specific differences that suggest a possible hybrid cell line.
Possibly contaminated. Parent cell lines (MGC-803) seems to be a derivative of HeLa and another cell of unknown origin. The STR profile of MGC-803 is highly similar to that of HeLa yet shows some specific differences that suggest a possible hybrid cell line.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706; PubMed=28107433). Originally thought to originate from a tongue squamous cell carcinoma.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706; PubMed=28107433). Originally thought to originate from a tongue squamous cell carcinoma.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Contaminated. Grand-parent cell line (MOBS-1) has been shown to be a U-937 derivative.
Contaminated. Ancestral cell line (MOBS-1) has been shown to be a U-937 derivative.
Contaminated. Ancestral cell line (MOBS-1) has been shown to be a U-937 derivative.
Contaminated. Ancestral cell line (MOBS-1) has been shown to be a U-937 derivative.
Contaminated. Ancestral cell line (MOBS-1) has been shown to be a U-937 derivative.
Contaminated. Ancestral cell line (MOBS-1) has been shown to be a U-937 derivative.
Contaminated. Ancestral cell line (MOBS-1) has been shown to be a U-937 derivative.
Contaminated. Ancestral cell line (MOBS-1) has been shown to be a U-937 derivative.
Contaminated. Ancestral cell line (MOBS-1) has been shown to be a U-937 derivative.
Contaminated. Parent cell line (SGC-7901) has been shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from the lymph node of a 56 year old female patient with a gastric carcinoma.
Contaminated. Parent cell line (SGC-7901) has been shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from the lymph node of a 56 year old female patient with a gastric carcinoma.
Contaminated. Parent cell line (SGC-7901) has been shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from the lymph node of a 56 year old female patient with a gastric carcinoma.
Contaminated. Parent cell line (SPC-A1) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (SPC-A1) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (OV-2008) has been shown to be a ME-180 derivative.
Contaminated. Parent cell line (OV-2008) has been shown to be a ME-180 derivative.
Possibly misidentified/contaminated. Shown to be identical to SBC-1 (JCRB web site and STR profile).
Contaminated. Shown to be a WISH derivative (PubMed=24520087). Originally thought to originate from an endometrium.
Contaminated. Shown to be a Hep 3B2.1-7 derivative. Original paper (PubMed=21406725) has been retracted.
Contaminated. Shown to be a Hep 3B2.1-7 derivative. Original paper (PubMed=21406725) has been retracted.
Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (HuL-1) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (HuL-1) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (HuL-1) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative.
Contaminated. Grand-parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative.
Contaminated. Grand-parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative.
Contaminated. Grand-parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative.
Contaminated. Grand-parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative.
Contaminated. Grand-parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative.
Contaminated. Parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative.
Contaminated. Parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative.
Contaminated. Parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative.
Contaminated. Parent cell line (HSG) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (HSG) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (HSG) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (HSG) has been shown to be a HeLa derivative.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a patient with a gingival carcinoma neck metastasis.
Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a patient with a gingival carcinoma neck metastasis.
Contaminated. Parent cell line (EPLC-65H) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (EPLC-65H) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (L-02) has been shown to be a HeLa derivative.
Contaminated. Parent cell line was shown to be a HeLa derivative.
Misidentified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be a B-lymphoblastoid cell line (PubMed=29533902).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be a B-lymphoblastoid cell line (PubMed=29533902).
Misidentified. Originally thought to be a Hodgkin lymphoma cell line but is probably a B-lymphoblastoid cell line (PubMed=29533902).
Contaminated. Shown to be a K-562 derivative (BCRC). Originally thought to originate from 50 year old male patient suffering from acute T-cell leukemia.
Misidentified/contaminated. Shown to be 100% identical to CG1000 (BCRC).
Contaminated. Shown to be a Siha derivative (BCRC). Originally thought to originate from the placenta of a 29 year old woman.
Contaminated. Shown to be a Siha derivative (BCRC). Originally thought to originate from the placenta of a 29 year old woman.
Contaminated. Shown to be a HeLa derivative (BCRC). Originally thought to originate from the TL cell line (CVCL_WU75) which was supposed to originate from the placenta of a 29 year old woman but is a SiHa contaminated cell line.
Contaminated. Shown to be a HeLa derivative (BCRC). Originally thought to originate from the placenta a 29 year old woman.
Contaminated. Shown to be a HeLa derivative (BCRC). Originally thought to originate from the placenta a 29 year old woman.
Contaminated. Parent cell line (OST) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (OST) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (BCaP-37) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (BCaP-37) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (BCaP-37) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (BCaP-37) has been shown to be a HeLa derivative.
Contaminated. Shown to be a HK-2 derivative (CCRID). Was originally thought to be a renal tubular epithelial cell line.
Contaminated. Shown to be a MCF-7 derivative (PubMed=22710073).
Contaminated. Shown to be a MCF-7 derivative (PubMed=22710073).
Contaminated. Shown to be a C-33 A derivative (PubMed=22710073).
Contaminated. Shown to be a C-33 A derivative (PubMed=22710073).
Contaminated. Shown to be a C-33 A derivative (PubMed=22710073).
Contaminated. Shown to be a DOV13 derivative (PubMed=22710073).
Contaminated. Shown to be a DOV13 derivative (PubMed=22710073).
Contaminated. Shown to be a DOV13 derivative (PubMed=22710073).
Contaminated. Shown to be a DOV13 derivative (PubMed=22710073).
Contaminated. Parent cell line (CH1) has been shown to be a PA-1 derivative.
Contaminated. Parent cell line (CH1) has been shown to be a PA-1 derivative.
Contaminated. Parent cell line (CH1) has been shown to be a PA-1 derivative.
Contaminated. Parent cell line (CH1) has been shown to be a PA-1 derivative.
Contaminated. Shown to be a SCLC-21H (or SCLC-22H) derivative (PubMed=10508494; PubMed=20143388).
Contaminated. Shown to be a SCLC-21H (or SCLC-22H) derivative (PubMed=10508494; PubMed=20143388).
Contaminated. Parent cell line (SCLC-16HC) has been shown to be a SCLC-21H (or SCLC-22H) derivative.
Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
Contaminated. Parent cell line (E006AA) has been shown to be a 786-O derivative.
Contaminated. Parent cell line (E006AA) has been shown to be a 786-O derivative.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Grand-parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Grand-parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Grand-parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Grand-parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Grand-parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Grand-parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Grand-parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Grand-parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Grand-parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Grand-parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Grand-parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Grand-parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Grand-parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Grand-parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
Contaminated. Parent cell line (41M) has been shown to be a OAW28 derivative.
Contaminated. Parent cell line (41M) has been shown to be a OAW28 derivative.
Contaminated. Shown to be a SW480 (or SW620) derivative (BCRC). Originally thought to originate from a 58 year old male patient with a sigmoid colorectal carcinoma.
Contaminated. Shown to be a SW480 (or SW620) derivative (BCRC). Originally thought to originate from a 80 year old female patient with a transverse colorectal carcinoma.
Contaminated. Parent cell line (CH1) has been shown to be a PA-1 derivative.
Contaminated. Parent cell line (41M) has been shown to be a OAW28 derivative.
Contaminated. Parent cell line (E006AA) has been shown to be a 786-O derivative.
Contaminated. Parent cell line (E006AA) has been shown to be a 786-O derivative.
Possibly contaminated. Indicated (PubMed=24532842) to have a near genetic identity with Hep-G2 cells. But they are functionally different from Hep-G2 cells since they support sporozoite invasion and liver stage exoerythrocytic development of Plasmodium falciparum and Plasmodium vivax. But STR profile from BEI Resources is identical to that of Hep-G2.
Possibly contaminated. Indicated (PubMed=24532842) to have a near genetic identity with Hep-G2 cells. But they are functionally different from Hep-G2 cells since they support sporozoite invasion and liver stage exoerythrocytic development of Plasmodium falciparum and Plasmodium vivax. But STR profile from BEI Resources is identical to that of Hep-G2.
Possibly contaminated. Indicated (PubMed=24532842) to have a near genetic identity with Hep-G2 cells. But they are functionally different from Hep-G2 cells since they support sporozoite invasion and liver stage exoerythrocytic development of Plasmodium falciparum and Plasmodium vivax. But STR profile from BEI Resources is identical to that of Hep-G2.